1
|
Nademanee K, Tei C. Two Faces of Brugada Syndrome: Electrical and Structural Diseases. JACC Clin Electrophysiol 2020; 6:1364-1366. [PMID: 33121664 DOI: 10.1016/j.jacep.2020.07.006] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2020] [Accepted: 07/01/2020] [Indexed: 11/16/2022]
Affiliation(s)
- Koonlawee Nademanee
- Faculty of Medicine, Department of Medicine, Chulalongkorn University, Bangkok, Thailand; Pacific Rim Electrophysiology Research Institute at Bumrungrad Hospital, Bangkok, Thailand; Pacific Rim Electrophysiology Research Institute, Las Vegas, Nevada, USA.
| | - Chuwa Tei
- Waon Therapy Research Institute, Tokyo, Japan
| |
Collapse
|
2
|
Kim WS, Kim HS, Shin J, Park JC, Yoo HW, Takenaka T, Tei C. Prevalence of Fabry Disease in Korean Men with Left Ventricular Hypertrophy. J Korean Med Sci 2019; 34:e63. [PMID: 30804731 PMCID: PMC6384437 DOI: 10.3346/jkms.2019.34.e63] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/15/2018] [Accepted: 01/21/2019] [Indexed: 11/25/2022] Open
Abstract
BACKGROUND Fabry disease is an X-linked recessive disorder caused by deficiency of the lysosomal enzyme α-galactosidase A (α-Gal A). Previous studies identified many cases of Fabry disease among men with left ventricular hypertrophy (LVH). The purpose of this study was to define the frequency of Fabry disease among Korean men with LVH. METHODS In this national prospective multicenter study, we screened Fabry disease in men with LVH on echocardiography. The criterion for LVH diagnosis was a maximum LV wall thickness 13 mm or greater. We screened 988 men with LVH for plasma α-Gal A activity. In patients with low α-Gal A activity (< 3 nmol/hr/mL), we searched for mutations in the α-galactosidase gene. RESULTS In seven men, α-Gal A activity was low. Three had previously identified mutations; Gly328Arg, Arg301Gln, and His46Arg. Two unrelated men had the E66Q variant associated with functional polymorphism. In two patients, we did not detect GLA mutations, although α-Gal A activity was low on repeated assessment. CONCLUSION We identified three patients (0.3%) with Fabry disease among unselected Korean men with LVH. Although the prevalence of Fabry disease was low in our study, early treatment of Fabry disease can result in a good prognosis. Therefore, in men with unexplained LVH, differential diagnosis of Fabry disease should be considered.
Collapse
Affiliation(s)
- Woo-Shik Kim
- Department of Internal Medicine, Kyung Hee University College of Medicine, Seoul, Korea
| | - Hyun Soo Kim
- Department of Medicine, Graduate School, Kyung Hee University, Seoul, Korea
| | - Jinho Shin
- Department of Internal Medicine, Hanyang University Seoul Hospital, Hanyang University College of Medicine, Seoul, Korea
| | - Jong Chun Park
- Department of Internal Medicine, Chonnam National University Hospital, Chonnam National University, Gwangju, Korea
| | - Han-Wook Yoo
- Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| | - Toshihiro Takenaka
- Department of Internal and Cardiovascular Medicine, Tarumizu Chuo Hospital, Kagoshima, Japan
| | - Chuwa Tei
- Waon Therapy Research Institute, Tokyo, Japan
- Department of Cardiology, Dokkyo Medical University, Tochigi, Japan
| |
Collapse
|
3
|
Obi S, Nakajima T, Hasegawa T, Nakamura F, Sakuma M, Toyoda S, Tei C, Inoue T. Heat induces myogenic transcription factors of myoblast cells via transient receptor potential vanilloid 1 (Trpv1). FEBS Open Bio 2018; 9:101-113. [PMID: 30652078 PMCID: PMC6325605 DOI: 10.1002/2211-5463.12550] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2018] [Revised: 09/25/2018] [Accepted: 10/30/2018] [Indexed: 12/17/2022] Open
Abstract
Exercise generates heat, blood flow, and metabolic changes, thereby inducing hypertrophy of skeletal muscle cells. However, the mechanism by which heat incudes hypertrophy in response to heat is not well known. Here, we hypothesized that heat would induce differentiation of myoblast cells. We investigated the underlying mechanism by which myoblast cells respond to heat. When mouse myoblast cells were exposed to 42 °C for over 30 min, the phosphorylation level of protein kinase C (PKC) and heat shock factor 1 (Hsf1) increased, and the mRNA and protein expression level of heat shock protein 70 (Hsp70) increased. Inhibitors of transient receptor potential vanilloid 1 (Trpv1), calmodulin, PKC, and Hsf1, and the small interfering RNA‐mediated knockdown of Trpv1 diminished those heat responses. Heat exposure increased the phosphorylation levels of thymoma viral proto‐oncogene 1 (Akt), mammalian target of rapamycin (mTOR), eukaryotic translation initiation factor 4E binding protein 1 (Eif4ebp1), and ribosomal protein S6 kinase, polypeptide 1 (S6K1). The knockdown of Trpv1 decreased these heat‐induced responses. Antagonists of Hsp70 inhibited the phosphorylation level of Akt. Finally, heat increased the protein expression level of skeletal muscle markers such as myocyte enhancer factor 2D, myogenic factor 5, myogenic factor 6, and myogenic differentiation 1. Heat also increased myotube formation. Knockdown of Trpv1 diminished heat‐induced increases of those proteins and myotube formation. These results indicate that heat induces myogenic transcription factors of myoblast cells through the Trpv1, calmodulin, PKC, Hsf1, Hsp70, Akt, mTOR, Eif4ebp1, and S6K1 pathway. Moreover, heat increases myotube formation through Trpv1.
Collapse
Affiliation(s)
- Syotaro Obi
- Research Support Center Dokkyo Medical University Tochigi Japan.,Department of Cardiovascular Medicine Dokkyo Medical University Tochigi Japan
| | - Toshiaki Nakajima
- Department of Cardiovascular Medicine Dokkyo Medical University Tochigi Japan.,Heart Center Dokkyo Medical University Hospital Tochigi Japan
| | - Takaaki Hasegawa
- Department of Cardiovascular Medicine Dokkyo Medical University Tochigi Japan
| | - Fumitaka Nakamura
- Third Department of Internal Medicine Teikyo University Chiba Medical Center Japan
| | - Masashi Sakuma
- Department of Cardiovascular Medicine Dokkyo Medical University Tochigi Japan
| | - Shigeru Toyoda
- Department of Cardiovascular Medicine Dokkyo Medical University Tochigi Japan.,Heart Center Dokkyo Medical University Hospital Tochigi Japan
| | - Chuwa Tei
- Department of Cardiovascular Medicine Dokkyo Medical University Tochigi Japan
| | - Teruo Inoue
- Research Support Center Dokkyo Medical University Tochigi Japan.,Department of Cardiovascular Medicine Dokkyo Medical University Tochigi Japan.,Heart Center Dokkyo Medical University Hospital Tochigi Japan
| |
Collapse
|
4
|
Källström M, Soveri I, Oldgren J, Laukkanen J, Ichiki T, Tei C, Timmerman M, Berglund L, Hägglund H. Effects of sauna bath on heart failure: A systematic review and meta-analysis. Clin Cardiol 2018; 41:1491-1501. [PMID: 30239008 DOI: 10.1002/clc.23077] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/17/2018] [Revised: 09/11/2018] [Accepted: 09/18/2018] [Indexed: 12/20/2022] Open
Abstract
BACKGROUND Sauna bath has potential as a lifestyle treatment modality for heart failure (HF). It is important to analyze the current evidence to help suggest paths of future study and potential for clinical application. HYPOTHESIS Sauna bath has a positive effect on HF patients. METHODS PubMed, Cochrane Library, and CINAHL databases were searched to identify randomized and nonrandomized controlled studies to compare effects of sauna bath with no sauna bath. Studies were searched for both infrared sauna bath and Finnish sauna bath. The strength of evidence was rated using a modified GRADE approach. Out of 1444 studies, nine met the inclusion criteria and were included in this review. Seven of these nine studies were included in the meta-analysis. Only studies with infrared sauna bath met the inclusion criteria. RESULTS In the meta-analysis, exposure to an infrared sauna bath in 60°C for 15 minutes, followed by a 30-minute rest in warm environment, five times a week for 2 to 4 weeks, was associated with a significant reduction in B-type natriuretic peptide, cardiothoracic ratio, and an improvement in left-ventricular ejection fraction. There was no significant effect on left-ventricular end-diastolic diameter, left atrial diameter, systolic blood pressure, or diastolic blood pressure. The strength of evidence varied from moderate to insufficient. CONCLUSION Infrared sauna bath was associated with short-term improvement in cardiac function. More evidence is needed about long-term effects of sauna bath and the effects of a Finnish sauna on cardiovascular health among patients with HF or other cardiovascular diseases.
Collapse
Affiliation(s)
- Miikka Källström
- Department of Medical Sciences, Uppsala University, Uppsala, Sweden
| | - Inga Soveri
- Department of Medical Sciences, Uppsala University, Uppsala, Sweden
| | - Jonas Oldgren
- Uppsala Clinical Research Center and Department of Medical Sciences, Uppsala University, Uppsala, Sweden
| | - Jari Laukkanen
- Faculty of Sport and Health Sciences and Central Finland Health Care District, Department of Internal Medicine, University of Jyväskylä, Jyväskylä, Finland.,Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland
| | - Tomoko Ichiki
- Cardiovascular Medicine, Mayo Clinic and Cardiology, International University of Health and Welfare, Rochester, Minnesota.,Cardiology, International University of Health and Welfare, Narita, Japan
| | - Chuwa Tei
- Waon Therapy Research Institute, Tokyo, Japan
| | - Mark Timmerman
- Department of Family Medicine, River Valley Clinic, Spring Green, Wisconsin
| | - Lars Berglund
- Uppsala Clinical Research Center and Department of Public Health and Caring Sciences/Geriatrics, Uppsala University, Uppsala, Sweden
| | - Hans Hägglund
- Department of Medical Sciences, Uppsala University, Uppsala, Sweden
| |
Collapse
|
5
|
Nakao YM, Miyamoto Y, Higashi M, Noguchi T, Ohishi M, Kubota I, Tsutsui H, Kawasaki T, Furukawa Y, Yoshimura M, Morita H, Nishimura K, Kada A, Goto Y, Okamura T, Tei C, Tomoike H, Naito H, Yasuda S. Sex differences in impact of coronary artery calcification to predict coronary artery disease. Heart 2018; 104:1118-1124. [PMID: 29331986 PMCID: PMC6031260 DOI: 10.1136/heartjnl-2017-312151] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/13/2017] [Revised: 11/17/2017] [Accepted: 11/28/2017] [Indexed: 01/01/2023] Open
Abstract
Objective To assess sex-specific differences regarding use of conventional risks and coronary artery calcification (CAC) to detect coronary artery disease (CAD) using coronary CT angiography (CCTA). Methods The Nationwide Gender-specific Atherosclerosis Determinants Estimation and Ischemic Cardiovascular Disease Prospective Cohort study is a prospective, multicentre, nationwide cohort study. Candidates with suspected CAD aged 50–74 years enrolled from 2008 to 2012. The outcome was obstructive CAD defined as any stenosis ≥50% by CCTA. We constructed logistic regression models for obstructive CAD adjusted for conventional risks (clinical model) and CAC score. Improvement in discrimination beyond risks was assessed by C-statistic; net reclassification index (NRI) for CAD probability of low (<30%), intermediate (30%–60%) and high (≥60%); and risk stratification capacity. Results Among 991 patients (456 women, 535 men; 65.2 vs 64.4 years old), women had lower CAC scores (median, 4 vs 60) and lower CAD prevalence (21.7% vs 37.0%) than men. CAC significantly improved model discrimination compared with clinical model in both sexes (0.66–0.79 in women vs 0.61–0.83 in men). The NRI for women was 0.33, which was much lower than that for men (0.71). Adding CAC to clinical model had a larger benefit in terms of moving an additional 43.3% of men to the most determinant categories (high or low risk) compared with −1.4% of women. Conclusions The addition of CAC to a prediction model based on conventional variables significantly improved the classification of risk in suspected patients with CAD, with sex differences influencing the predictive ability. Trial registration number UMIN-CTR Clinical Trial: UMIN000001577.
Collapse
Affiliation(s)
- Yoko M Nakao
- Department of Preventive Medicine and Epidemiologic informatics, National Cerebral and Cardiovascular Center, Suita, Japan
| | - Yoshihiro Miyamoto
- Department of Preventive Medicine and Epidemiologic informatics, National Cerebral and Cardiovascular Center, Suita, Japan
| | - Masahiro Higashi
- Department of Radiology, National Hospital Organization Osaka National Hospital, Osaka, Japan
| | - Teruo Noguchi
- Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan
| | - Mitsuru Ohishi
- Department of Cardiovascular Medicine and Hypertension, Graduate School of Medicine Kagoshima University, Kagoshima, Japan
| | - Isao Kubota
- Department of Cardiology, Pulmonology and Nephrology, Yamagata University School of Medicine, Yamagata, Japan
| | - Hiroyuki Tsutsui
- Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
| | | | - Yutaka Furukawa
- Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Japan
| | - Michihiro Yoshimura
- Division of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
| | - Hideaki Morita
- Department of Cardiology, Osaka Medical College, Osaka, Japan
| | - Kunihiro Nishimura
- Center for Cerebral and Cardiovascular Disease Information, National Cerebral and Cardiovascular Center, Suita, Japan
| | - Akiko Kada
- Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
| | - Yoichi Goto
- Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan
| | - Tomonori Okamura
- Department of Preventive Medicine and Public Health, Keio University, Tokyo, Japan
| | - Chuwa Tei
- Waon Therapy Research Institute, Tokyo, Japan
| | | | | | - Satoshi Yasuda
- Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan
| |
Collapse
|
6
|
Saigo M, Ogawa M, Yamashita T, Biro S, Minagoe S, Maruyama I, Tei C, Abe S. Imbalance of Plasminogen Activator Inhibitor-I/ Tissue Plasminogen Activator and Tissue Factor/Tissue Factor Pathway Inhibitor in Young Japanese Men with Myocardial Infarction. Thromb Haemost 2017. [DOI: 10.1055/s-0037-1616051] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
SummaryTo evaluate the association between haemostatic parameters and increased risk of myocardial infarction (MI) at a young age, we measured fibrinogen, factor VII, antithrombin III, protein C, protein S, tissue factor (TF), free form tissue factor pathway inhibitor (TFPI), plasminogen, 2-antiplasmin, tissue plasminogen activator (tPA), plasminogen activator inhibitor-I (PAI-I), and lipoprotein (a) in 140 young men with MI before age 45 and 150 age-matched healthy men. TF, TF/TFPI ratio, PAI-I, PAI-I/tPA ratio, plasminogen, and lipoprotein (a) in young MI patients were all significantly higher than controls, while TFPI, antithrombin III, and tPA were significantly lower (P <0.001 of each). Significant determinants of MI risk were PAI-I/tPA ratio (R2 = 0.300, P <0.001), TF/TFPI ratio (R2 = 0.049, P <0.001), antithrombin III (R2 = 0.034, P <0.001), hyperlipidaemia (R2 = 0.019, P = 0.004), diabetes (R2 = 0.014, P = 0.015), lipoprotein (a) (R2 = 0.012, P = 0.023), 2-antiplasmin (R2 = 0.014, P = 0.012), and protein C (R2 = 0.012, P = 0.018). We conclude that the imbalances of PAI-I/tPA and TF/TFPI are significantly associated with MI at a young age, perhaps mediated via impaired fibrinolytic activity.
Collapse
|
7
|
Saigo M, Ogawa M, Maruyama I, Tei C, Abe S. Suppression of Fibrinolytic Activity and Obesity in Young Patients with Myocardial Infarction. Thromb Haemost 2017. [DOI: 10.1055/s-0037-1613321] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
8
|
Amano H, Abe S, Hirose S, Waku R, Masuyama T, Sakuma M, Toyoda S, Taguchi I, Inoue T, Tei C. Comparison of echocardiographic parameters to assess right ventricular function in pulmonary hypertension. Heart Vessels 2017; 32:1214-1219. [PMID: 28527022 DOI: 10.1007/s00380-017-0991-6] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/27/2017] [Accepted: 05/12/2017] [Indexed: 01/18/2023]
Abstract
Although measurement of right ventricular ejection fraction (RVEF) may be relevant for evaluation of therapeutic efficacy and/or prognosis in patients with pulmonary hypertension, RVEF obtained by echocardiography has limited accuracy. In contrast, radionuclide and/or magnetic resonance imaging can measure RVEF more reliably. In this study, we investigated the relationship between RVEF measured by radionuclide angiography and the echocardiographic parameters that are recommended by the American Society of Echocardiography as representative of right heart function. There were 23 study participants with pulmonary hypertension who underwent radionuclide angiography and 2-dimensional and Doppler echocardiography (n = 30 measurements). RVEF measured by radionuclide angiography correlated with right ventricular Tei index (RV Tei index) measured by Doppler echocardiography (r = -0.601, P < 0.0005). Receiver operating characteristic curve analysis showed that an RV Tei index cut-off value of 0.371 was the best of predictor of RVEF ≤35% (area under the curve = 0.768, sensitivity = 0.857, selectivity = 0.667). Multiple regression analysis showed that RVEF was correlated with the RV Tei index, and this association was independent of other echocardiographic right ventricular function parameters (r = -0.644, P < 0.005). The RV Tei index measured by Doppler echocardiography may be an acceptable surrogate marker of RVEF in patients with pulmonary hypertension.
Collapse
Affiliation(s)
- Hirohisa Amano
- The Department of Cardiovascular Medicine, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi, 321-0293, Japan
| | - Shichiro Abe
- The Department of Cardiovascular Medicine, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi, 321-0293, Japan.
| | - Suguru Hirose
- The Department of Cardiovascular Medicine, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi, 321-0293, Japan
| | - Ryutaro Waku
- The Department of Cardiovascular Medicine, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi, 321-0293, Japan
| | - Taiki Masuyama
- The Department of Cardiovascular Medicine, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi, 321-0293, Japan
| | - Masashi Sakuma
- The Department of Cardiovascular Medicine, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi, 321-0293, Japan
| | - Shigeru Toyoda
- The Department of Cardiovascular Medicine, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi, 321-0293, Japan
| | - Isao Taguchi
- The Department of Cardiology, Koshigaya Hospital, Dokkyo Medical University School of Medicine, Koshigaya, Japan
| | - Teruo Inoue
- The Department of Cardiovascular Medicine, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi, 321-0293, Japan
| | - Chuwa Tei
- The Department of Cardiovascular Medicine, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi, 321-0293, Japan.,Waon Therapy Research Institute, Tokyo, Japan
| |
Collapse
|
9
|
Nitta H, Katagiri S, Nagasawa T, Izumi Y, Ishikawa I, Izumiyama H, Uchimura I, Kanazawa M, Chiba H, Matsuo A, Utsunomiya K, Tanabe H, Takei I, Asanami S, Kajio H, Ono T, Hayashi Y, Ueki K, Tsuji M, Kurachi Y, Yamanouchi T, Ichinokawa Y, Inokuchi T, Fukui A, Miyazaki S, Miyauchi T, Kawahara R, Ogiuchi H, Yoshioka N, Negishi J, Mori M, Mogi K, Saito Y, Tanzawa H, Nishikawa T, Takada N, Nanjo K, Morita N, Nakamura N, Kanamura N, Makino H, Nishimura F, Kobayashi K, Higuchi Y, Sakata T, Yanagisawa S, Tei C, Ando Y, Hanada N, Inoue S. The number of microvascular complications is associated with an increased risk for severity of periodontitis in type 2 diabetes patients: Results of a multicenter hospital-based cross-sectional study. J Diabetes Investig 2017; 8:677-686. [PMID: 28129466 PMCID: PMC5583958 DOI: 10.1111/jdi.12633] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/18/2016] [Revised: 11/25/2016] [Accepted: 01/18/2017] [Indexed: 01/06/2023] Open
Abstract
Aims/Introduction To explore the relationships between periodontitis and microvascular complications as well as glycemic control in type 2 diabetes patients. Materials and Methods This multicenter, hospital‐based, cross‐sectional study included 620 patients with type 2 diabetes. We compared the prevalence and severity of periodontitis between patients with ≥1 microvascular complication and those without microvascular complications. We also compared the prevalence and severity of periodontitis among patients with different degrees of glycemic control. Results After adjusting for confounding factors, multiple logistic regression analysis showed that the severity of periodontitis was significantly associated with the number of microvascular complications (odds ratio 1.3, 95% confidence interval 1.1–1.6), glycated hemoglobin ≥8.0% (64 mmol/mol; odds ratio 1.6; 95% confidence interval 1.1–2.3), and older age (≥50 years; odds ratio 1.7; 95% confidence interval 1.1–2.6). However, the prevalence of periodontitis was not significantly associated with the number of microvascular complications, but was associated with male sex, high glycated hemoglobin (≥8.0% [64 mmol/mol]), older age (≥40 years), longer duration of diabetes (≥15 years) and fewer teeth (≤25). Furthermore, propensity score matching for age, sex, diabetes duration and glycated hemoglobin showed that the incidence of severe periodontitis was significantly higher among patients with microvascular complications than among those without microvascular complications (P < 0.05). Conclusions The number of microvascular complications is a risk factor for more severe periodontitis in patients with type 2 diabetes, whereas poor glycemic control is a risk factor for increased prevalence and severity of periodontitis.
Collapse
Affiliation(s)
- Hiroshi Nitta
- Medical and Dental Hospitals, Tokyo Medical and Dental University, Tokyo, Japan
| | - Sayaka Katagiri
- Medical and Dental Hospitals, Tokyo Medical and Dental University, Tokyo, Japan
| | - Toshiyuki Nagasawa
- Medical and Dental Hospitals, Tokyo Medical and Dental University, Tokyo, Japan
| | - Yuichi Izumi
- Kagoshima University Medical and Dental Hospital, Kagoshima, Japan
| | - Isao Ishikawa
- Medical and Dental Hospitals, Tokyo Medical and Dental University, Tokyo, Japan
| | - Hajime Izumiyama
- Medical and Dental Hospitals, Tokyo Medical and Dental University, Tokyo, Japan
| | - Isao Uchimura
- Medical and Dental Hospitals, Tokyo Medical and Dental University, Tokyo, Japan
| | | | | | | | | | | | | | | | - Hiroshi Kajio
- Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan
| | - Toaki Ono
- Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan
| | | | - Kiichi Ueki
- Nihon University Itabashi Hospital, Tokyo, Japan
| | | | | | | | | | | | - Akiko Fukui
- Toho University Omori Hospital, Tokyo, Japan
| | | | | | | | | | | | - Jun Negishi
- Hokkaido University Hospital, Sapporo, Japan
| | | | - Kenji Mogi
- Gunma University Hospital, Maebashi, Japan
| | | | | | | | | | - Kishio Nanjo
- Wakayama Medical University Hospital, Wakayama, Japan
| | - Nobuo Morita
- Wakayama Medical University Hospital, Wakayama, Japan
| | - Naoto Nakamura
- University Hospital, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - Narisato Kanamura
- University Hospital, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - Hirofumi Makino
- University Hospital, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | | | | | - Yoshinori Higuchi
- National Hospital Organization Kyusyu Medical Center, Fukuoka, Japan
| | | | | | - Chuwa Tei
- Kagoshima University Medical and Dental Hospital, Kagoshima, Japan
| | - Yuichi Ando
- Department of Oral Science, National Institute of Infectious Diseases, Japan
| | - Nobuhiro Hanada
- Department of Oral Science, National Institute of Infectious Diseases, Japan
| | - Shuji Inoue
- Department of Nutrition and Physiology, Faculty of Home Economics, Kyoritsu Women's University, Tokyo, Japan
| |
Collapse
|
10
|
Ichiki T, Burnett JC, Scott CG, Heublein DM, Miyata M, Kinugawa K, Inoue T, Tei C. Neurohumoral Modulation During Waon Therapy in Chronic Heart Failure - Subanalysis of Waon-CHF Study. Circ J 2017; 81:709-716. [PMID: 28202884 DOI: 10.1253/circj.cj-16-1117] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
BACKGROUND Heart failure (HF) is a disease of neurohumoral dysfunction and current pharmacological therapies for HF have not improved mortality rates, thus requiring additional new strategies. Waon therapy for HF patients may be a complementary strategy with peripheral vasodilation via nitric oxide. We hypothesized that Waon therapy would improve neurohumoral factors, such as natriuretic peptides (NP) and the renin-angiotensin-aldosterone system (RAAS) in HF.Methods and Results:Plasma samples were collected from patients enrolled in the WAON-CHF Study (Waon therapy (n=77) or control (n=73)) before and after the treatment. B-type NP (BNP), C-type NP (CNP), and aldosterone (Aldo) levels were measured by respective specific radioimmunoassays. Although clinical parameters significantly improved in the Waon group compared with the control group, BNP, Aldo, and CNP levels were not statistically different between groups. On subanalysis with patient variables, BNP levels were improved in the Waon group treated with angiotensin-converting enzyme inhibitor/angiotensin-receptor blocker or spironolactone. In addition, Aldo levels were improved in the Waon group patients with diabetes mellitus, hypertension, and inotrope use, and CNP levels were improved in Waon group patients with estimated glomerular filtration rate <60 mL/min/1.73 m2. These changes were not observed in the control group. CONCLUSIONS Waon therapy may accelerate the favorable actions of RAAS modulators in HF. (WAON-CHF Study: UMIN000006705).
Collapse
Affiliation(s)
- Tomoko Ichiki
- Cardiorenal Research Laboratory, Department of Cardiovascular Diseases, Mayo Clinic
| | - John C Burnett
- Cardiorenal Research Laboratory, Department of Cardiovascular Diseases, Mayo Clinic
| | | | - Denise M Heublein
- Cardiorenal Research Laboratory, Department of Cardiovascular Diseases, Mayo Clinic
| | - Masaaki Miyata
- Department of Cardiovascular Medicine and Hypertension, Kagoshima University Hospital
| | - Koichiro Kinugawa
- Internal Medicine II, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama
| | - Teruo Inoue
- Department of Cardiovascular Medicine, Dokkyo Medical University
| | - Chuwa Tei
- Department of Cardiovascular Medicine, Dokkyo Medical University.,Waon Therapy Research Institute
| | | |
Collapse
|
11
|
Kubo T, Ochi Y, Baba Y, Hirota T, Tanioka K, Yamasaki N, Yoshimitsu M, Higuchi K, Takenaka T, Nakajima K, Togawa T, Tsukimura T, Sano S, Tei C, Sakuraba H, Kitaoka H. Prevalence and clinical features of Fabry disease in Japanese male patients with diagnosis of hypertrophic cardiomyopathy. J Cardiol 2017; 69:302-307. [DOI: 10.1016/j.jjcc.2016.05.014] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/26/2016] [Revised: 04/23/2016] [Accepted: 05/24/2016] [Indexed: 10/21/2022]
|
12
|
Kyo S, Imanaka K, Masuda M, Miyata T, Morita K, Morota T, Nomura M, Saiki Y, Sawa Y, Sueda T, Ueda Y, Yamazaki K, Yozu R, Iwamoto M, Kawamoto S, Koyama I, Kudo M, Matsumiya G, Orihashi K, Oshima H, Saito S, Sakamoto Y, Shigematsu K, Taketani T, Komuro I, Takamoto S, Tei C, Yamamoto F. Guidelines for Perioperative Cardiovascular Evaluation and Management for Noncardiac Surgery (JCS 2014) ― Digest Version ―. Circ J 2017; 81:245-267. [DOI: 10.1253/circj.cj-66-0135] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
13
|
Abstract
Objective Chronic fatigue syndrome (CFS) is a complex disorder, with no consensus on therapeutic options. However, Waon therapy has been reported to be an effective treatment. The purpose of this study was to evaluate changes in the cerebral blood flow (CBF) before and after Waon therapy in CFS patients and to investigate the correlation between such changes and the therapeutic efficacy of Waon therapy. Methods Eleven patients (2 men and 9 women, mean age 27 years old) diagnosed with CFS participated in the study. The disease duration was 8-129 months, and the performance status was 5-8 (on a scale of 0-9). All patients underwent CBF scintigraphy using brain single-photon emission computed tomography (SPECT) with technetium-99m ethyl cysteinate dimer (99mTc-ECD) before and after Waon therapy. CBF changes after Waon therapy were evaluated using a statistical analysis of imaging data, which was performed with a statistical parametric mapping software program (SPM5). Results Waon therapy reduced symptoms in all 11 patients. We also observed an increase in the CBF within the prefrontal region, orbitofrontal region, and right temporal lobe. These results indicated that an improvement in clinical symptoms was linked to an increase in the CBF. Conclusion The results indicated abnormalities of the cerebral function in the prefrontal region, orbitofrontal region, and right temporal lobe in CFS patients and that Waon therapy improved the cerebral function and symptoms in CFS patients by increasing the regional CBF. To our knowledge, this is the first report to clarify the CBF changes in CFS patients before and after Waon therapy.
Collapse
Affiliation(s)
- Takao Munemoto
- Department of Cardiovascular, Respiratory and Metabolic Medicine, Graduate School of Medicine, Kagoshima University, Japan
- Kagoshima Women's College, Japan
| | - Yuji Soejima
- Department of Cardiovascular, Respiratory and Metabolic Medicine, Graduate School of Medicine, Kagoshima University, Japan
- National Institute of Fitness and Sports in Kanoya, Japan
| | | | - Yoshiaki Nakabeppu
- Department of Radiology, Graduate School of Medicine, Kagoshima University, Japan
| | - Chuwa Tei
- Department of Cardiovascular, Respiratory and Metabolic Medicine, Graduate School of Medicine, Kagoshima University, Japan
- Waon Therapy Research Institute, Japan
| |
Collapse
|
14
|
Obi S, Nakajima T, Hasegawa T, Kikuchi H, Oguri G, Takahashi M, Nakamura F, Yamasoba T, Sakuma M, Toyoda S, Tei C, Inoue T. Heat induces interleukin-6 in skeletal muscle cells via TRPV1/PKC/CREB pathways. J Appl Physiol (1985) 2016; 122:683-694. [PMID: 27979980 DOI: 10.1152/japplphysiol.00139.2016] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2016] [Revised: 12/08/2016] [Accepted: 12/08/2016] [Indexed: 12/18/2022] Open
Abstract
Interleukin-6 (IL-6) is released from skeletal muscle cells and induced by exercise, heat, catecholamine, glucose, lipopolysaccharide, reactive oxygen species, and inflammation. However, the mechanism that induces release of IL-6 from skeletal muscle cells remains unknown. Thermosensitive transient receptor potential (TRP) proteins such as TRPV1-4 play vital roles in cellular functions. In this study we hypothesized that TRPV1 senses heat, transmits a signal into the nucleus, and produces IL-6. The purpose of the present study is to investigate the underlying mechanisms whereby skeletal muscle cells sense and respond to heat. When mouse myoblast cells were exposed to 37-42°C for 2 h, mRNA expression of IL-6 increased in a temperature-dependent manner. Heat also increased IL-6 secretion in myoblast cells. A fura 2 fluorescence dual-wavelength excitation method showed that heat increased intracellular calcium flux in a temperature-dependent manner. Intracellular calcium flux and IL-6 mRNA expression were increased by the TRPV1 agonists capsaicin and N-arachidonoyldopamine and decreased by the TRPV1 antagonists AMG9810 and SB366791 and siRNA-mediated knockdown of TRPV1. TRPV2, 3, and 4 agonists did not change intracellular calcium flux. Western blotting with inhibitors demonstrated that heat increased phosphorylation levels of TRPV1, followed by PKC and cAMP response element-binding protein (CREB). PKC inhibitors, Gö6983 and staurosporine, CREB inhibitors, curcumin and naphthol AS-E, and knockdown of CREB suppressed the heat-induced increases in IL-6. These results indicate that heat increases IL-6 in skeletal muscle cells through the TRPV1, PKC, and CREB signal transduction pathway.NEW & NOTEWORTHY Heat increases the release of interleukin-6 (IL-6) from skeletal muscle cells. IL-6 has been shown to serve immune responses and metabolic functions in muscle. It can be anti-inflammatory as well as proinflammatory. However, the mechanism that induces release of IL-6 from skeletal muscle cells remains unknown. Here we show that heat increases IL-6 in skeletal muscle cells through the transient receptor potential vannilloid 1, PKC, and cAMP response element-binding protein signal transduction pathway.
Collapse
Affiliation(s)
- Syotaro Obi
- Research Support Center, Dokkyo Medical University, Tochigi, Japan.,Department of Cardiovascular Medicine, Dokkyo Medical University, Tochigi, Japan
| | - Toshiaki Nakajima
- Department of Cardiovascular Medicine, Dokkyo Medical University, Tochigi, Japan; .,Heart Center, Dokkyo Medical University, Tochigi, Japan
| | - Takaaki Hasegawa
- Department of Cardiovascular Medicine, Dokkyo Medical University, Tochigi, Japan
| | - Hironobu Kikuchi
- Department of Cardiovascular Medicine, University of Tokyo, Tokyo, Japan
| | - Gaku Oguri
- Department of Cardiovascular Medicine, University of Tokyo, Tokyo, Japan
| | - Masao Takahashi
- Department of Cardiovascular Medicine, University of Tokyo, Tokyo, Japan
| | - Fumitaka Nakamura
- Third Department of Internal Medicine, Teikyo University Chiba Medical Center, Chiba, Japan
| | - Tatsuya Yamasoba
- Department of Otolaryngology, University of Tokyo, Tokyo, Japan; and
| | - Masashi Sakuma
- Department of Cardiovascular Medicine, Dokkyo Medical University, Tochigi, Japan
| | - Shigeru Toyoda
- Department of Cardiovascular Medicine, Dokkyo Medical University, Tochigi, Japan
| | - Chuwa Tei
- Department of Cardiovascular Medicine, Dokkyo Medical University, Tochigi, Japan.,Waon Therapy Research Institute, Tokyo, Japan
| | - Teruo Inoue
- Research Support Center, Dokkyo Medical University, Tochigi, Japan.,Department of Cardiovascular Medicine, Dokkyo Medical University, Tochigi, Japan
| |
Collapse
|
15
|
Tei C. [Waon Therapy]. Nihon Rinsho 2016; 74 Suppl 4 Pt 1:635-639. [PMID: 27534244] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
|
16
|
Tei C, Imamura T, Kinugawa K, Inoue T, Masuyama T, Inoue H, Noike H, Muramatsu T, Takeishi Y, Saku K, Harada K, Daida H, Kobayashi Y, Hagiwara N, Nagayama M, Momomura S, Yonezawa K, Ito H, Gojo S, Akaishi M, Miyata M, Ohishi M. Waon Therapy for Managing Chronic Heart Failure - Results From a Multicenter Prospective Randomized WAON-CHF Study. Circ J 2016; 80:827-34. [PMID: 27001189 DOI: 10.1253/circj.cj-16-0051] [Citation(s) in RCA: 40] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
BACKGROUND Waon therapy improves heart failure (HF) symptoms, but further evidence in patients with advanced HF remains uncertain. METHODS AND RESULTS In 19 institutes, we prospectively enrolled hospitalized patients with advanced HF, who had plasma levels of B-type natriuretic peptide (BNP) >500 pg/ml on admission and BNP >300 pg/ml regardless of more than 1 week of medical therapy. Enrolled patients were randomized into Waon therapy or control groups. Waon therapy was performed once daily for 10 days with a far infrared-ray dry sauna maintained at 60℃ for 15 min, followed by bed rest for 30 min covered with a blanket. The primary endpoint was the ratio of BNP before and after treatment. In total, 76 Waon therapy and 73 control patients (mean age 66 years, men 61%, mean plasma BNP 777 pg/ml) were studied. The groups differed only in body mass index and the frequency of diabetes. The plasma BNP, NYHA classification, 6-min walk distance (6MWD), and cardiothoracic ratio significantly improved only in the Waon therapy group. Improvements in NYHA classification, 6MWD, and cardiothoracic ratio were significant in the Waon therapy group, although the change in plasma BNP did not reach statistical significance. No serious adverse events were observed in either group. CONCLUSIONS Waon therapy, a holistic soothing warmth therapy, showed clinical advantages in safety and efficacy among patients with advanced HF.
Collapse
|
17
|
Watanabe H, Shiomi H, Nakatsuma K, Morimoto T, Taniguchi T, Furukawa Y, Nakagawa Y, Horie M, Kimura T, Kimura T, Sakata R, Marui A, Matsuda M, Mitsuoka H, Onoe M, Nakagawa Y, Yamanaka K, Fujiwara H, Takatsu Y, Ohno N, Nohara R, Murakami T, Takeda T, Nobuyoshi M, Iwabuchi M, Hanyu M, Tatami R, Matsushita T, Shirotani M, Nishiwaki N, Kita T, Furukawa Y, Okada Y, Kato H, Eizawa H, Is K, Tanaka M, Nakayama S, Lee JD, Nakano A, Koshiji T, Morioka K, Takizawa A, Shimamoto M, Yamazaki F, Takahashi M, Nishizawa J, Horie M, Takashima H, Tamura T, Aota M, Takahashi M, Tabata T, Tei C, Hamasaki S, Imoto Y, Yamamoto H, Kambara H, Doi O, Matsuda K, Nara M, Mitsudo K, Kadota K, Komiya T, Miki S, Mizoguchi T, Nakajima H, Ogawa H, Sugiyama S, Kawasuji M, Moriyama S, Hattori R, Aoyama T, Araki M, Suwa S, Tanbara K, Kitagawa K, Yamauchi M, Okamoto N, Fujino Y, Tezuka S, Saeki A, Hanazawa M, Sato Y, Hibi C, Sasae H, Takinami E, Uchida Y, Yamamoto Y, Nishida S, Yoshimoto M, Maeda S, Miki I, Minematsu S, Abe M, Shiomi H, Tada T, Tazaki J, Kato Y, Hayano M, Tokushige A, Natsuaki M, Nakajima T. Clinical efficacy of thrombus aspiration on 5-year clinical outcomes in patients with ST-segment elevation acute myocardial infarction undergoing percutaneous coronary intervention. J Am Heart Assoc 2015; 4:e001962. [PMID: 26077588 PMCID: PMC4599536 DOI: 10.1161/jaha.115.001962] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Background Adjunctive thrombus aspiration (TA) during primary percutaneous coronary intervention (PCI) was reported to promote better coronary and myocardial reperfusion. However, long-term mortality benefit of TA remains controversial. The objective of this study is to investigate the clinical impact of TA on long-term clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary PCI. Methods and Results The CREDO-Kyoto AMI Registry is a large-scale cohort study of acute myocardial infarction patients undergoing coronary revascularization in 2005–2007 at 26 hospitals in Japan. Among 5429 patients enrolled in the registry, the current study population consisted of 3536 patients who arrived at the hospital within 12 hours after the symptom onset and underwent primary PCI. Clinical outcomes were compared between the 2 patient groups with or without TA. During primary PCI procedures, 2239 out of 3536 (63%) patients underwent TA (TA group). The cumulative 5-year incidence of all-cause death was significantly lower in the TA group than in the non-TA group (18.5% versus 23.9%, log-rank P<0.001). After adjusting for confounders, however, the risk for all-cause death in the TA group was not significantly lower than that in the non-TA group (hazard ratio: 0.90, 95% CI: 0.76 to 1.06, P=0.21). The adjusted risks for cardiac death, myocardial infarction, stroke, and target-lesion revascularization were also not significantly different between the 2 groups. Conclusions Adjunctive TA during primary PCI was not associated with better 5-year mortality in STEMI patients.
Collapse
Affiliation(s)
- Hiroki Watanabe
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.)
| | - Hiroki Shiomi
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.)
| | - Kenji Nakatsuma
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.)
| | - Takeshi Morimoto
- Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.)
| | - Tomohiko Taniguchi
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.)
| | - Yutaka Furukawa
- Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.)
| | | | - Minoru Horie
- Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Takeshi Kimura
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.)
| | | | - Takeshi Kimura
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Ryuzo Sakata
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Akira Marui
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Mitsuo Matsuda
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Hirokazu Mitsuoka
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Masahiko Onoe
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Yoshihisa Nakagawa
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Kazuo Yamanaka
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Hisayoshi Fujiwara
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Yoshiki Takatsu
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Nobuhisa Ohno
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Ryuji Nohara
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Tomoyuki Murakami
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Teruki Takeda
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Masakiyo Nobuyoshi
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Masashi Iwabuchi
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Michiya Hanyu
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Ryozo Tatami
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Tsutomu Matsushita
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Manabu Shirotani
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Noboru Nishiwaki
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Toru Kita
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Yutaka Furukawa
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Yukikatsu Okada
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Hiroshi Kato
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Hiroshi Eizawa
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Katsuhisa Is
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Masaru Tanaka
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Shogo Nakayama
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Jong-Dae Lee
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Akira Nakano
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Takaaki Koshiji
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Koichi Morioka
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Akinori Takizawa
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Mitsuomi Shimamoto
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Fumio Yamazaki
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Masaaki Takahashi
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Junichiro Nishizawa
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Minoru Horie
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Hiroyuki Takashima
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Takashi Tamura
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Masaki Aota
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Mamoru Takahashi
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Takafumi Tabata
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Chuwa Tei
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Shuichi Hamasaki
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Yutaka Imoto
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Hiroyuki Yamamoto
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Hirofumi Kambara
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Osamu Doi
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Katsuhiko Matsuda
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Masafumi Nara
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Kazuaki Mitsudo
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Kazushige Kadota
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Tatsuhiko Komiya
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Shinji Miki
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Tetsu Mizoguchi
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Hiroyuki Nakajima
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Hisao Ogawa
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Seigo Sugiyama
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Michio Kawasuji
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Syuji Moriyama
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Ryuichi Hattori
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Takeshi Aoyama
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Makoto Araki
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Satoru Suwa
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Keiichi Tanbara
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Kumiko Kitagawa
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Misato Yamauchi
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Naoko Okamoto
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Yumika Fujino
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Saori Tezuka
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Asuka Saeki
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Miya Hanazawa
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Yuki Sato
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Chikako Hibi
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Hitomi Sasae
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Emi Takinami
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Yuriko Uchida
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Yuko Yamamoto
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Satoko Nishida
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Mai Yoshimoto
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Sachiko Maeda
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Izumi Miki
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Saeko Minematsu
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Mitsuru Abe
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Hiroki Shiomi
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Tomohisa Tada
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Junichi Tazaki
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Yoshihiro Kato
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Mamoru Hayano
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Akihiro Tokushige
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Masahiro Natsuaki
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| | - Tetsu Nakajima
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (H.W., H.S., K.N., T.T., T.K.) Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan (T.M.) Division of Cardiology, Kobe City Medical Center General Hospital, Kobe, Japan (Y.F.) Division of Cardiology, Tenri Hospital, Nara, Japan (Y.N.) Departments of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan (M.H.)
| |
Collapse
|
18
|
Abstract
OBJECTIVE Chronic fatigue syndrome (CFS) is a disabling condition of unknown etiology, and no definitive therapy has been identified to date. We developed Waon therapy, a form of thermal therapy using a far-infrared dry sauna, and in this study herein examined its feasibility and safety in patients with CFS. METHODS Ten consecutive inpatients with CFS stayed in a 60°C sauna for 15 minutes and then rested on a bed under a blanket for an additional 30 minutes outside the sauna room. The treatments were performed once a day, five days a week for four weeks. Perceived fatigue, the primary outcome measure, was evaluated using a numerical rating scale before, during (two weeks after the commencement of therapy) and after therapy. The pain level, evaluated using a numerical rating scale, mood, assessed using the Profile of Mood States questionnaire, and performance status, assessed using a scale developed for CFS patients were also examined before and after therapy. RESULTS Perceived fatigue significantly decreased after therapy, although no significant reductions were observed during therapy. In addition, a negative mood, including anxiety, depression and fatigue, and the performance status significantly improved after therapy. However, the levels of pain and vigor did not change significantly. No patients reported any adverse effects during the therapy. CONCLUSION These findings suggest that Waon therapy may be a useful and safe treatment for CFS.
Collapse
Affiliation(s)
- Yuji Soejima
- Department of Cardiovascular, Respiratory and Metabolic Medicine, Graduate School of Medicine, Kagoshima University, Japan
| | | | | | | | | | | |
Collapse
|
19
|
Tomoike H, Yokoyama H, Sumita Y, Hanai S, Kada A, Okamura T, Yoshikawa J, Doi Y, Hori M, Tei C. Nationwide Distribution of Cardiovascular Practice in Japan – Results of Japanese Circulation Society 2010 Annual Survey –. Circ J 2015; 79:1058-67. [DOI: 10.1253/circj.cj-14-1214] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
| | | | | | | | | | - Tomonori Okamura
- Department of Preventive Medicine and Public Health, School of Medicine, Keio University
| | | | | | - Masatsugu Hori
- Osaka Medical Center for Cancer and Cardiovascular Diseases
| | | | | |
Collapse
|
20
|
Matsushita K, Ozaki A, Inoue H, Kaieda T, Akimoto M, Satomura A, Arima N, Hamada H, Suruga Y, Aoki N, Fujiwara H, Tei C. Stevens–Johnson syndrome induced by mizoribine in a patient with systemic lupus erythematosus. Mod Rheumatol 2014. [DOI: 10.3109/s10165-006-0467-5] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
21
|
Yoshitama T, Yamaguchi A, Izumihara T, Matsuda T, Nagai S, Niimura T, Tei C. Comparative evaluation of KL-6 and surfactant protein D as serum markers for interstitial pneumonia associated with collagen diseases. Mod Rheumatol 2014; 11:121-6. [DOI: 10.3109/s101650170022] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
22
|
Abstract
Human T-lymphotropic virus type I (HTLV-I) is the causative agent in adult T-cell leukemia and HTLV-I associated myelopathy. Some other diseases such as uveitis, chronic thyroiditis, Sjögren syndrome, arthritis, acute myeloid leukemia and myelodysplastic syndrome may be also associated with HTLV-I. Several case reports have suggested the possible combination of idiopathic thrombocytopenic purpura (ITP) and HTLV-I infection. In these studies and from our current report, we found 17 patients (22.1%) with HTLV-I infection among 77 ITP patients. The prevalence of HTLV-I infection among ITP patients was higher than that of healthy volunteers (5 approximately 10%). The ITP patients with HTLV-I infection were older than the patients without HTLV-I infection, and the ITP patients with HTLV-I infection had poor response to prednisolone therapy. Among 17 ITP patients with HTLV-I infection, 9 patients received prednisolone therapy. Although most patients had transient increase of platelet counts, only two of them had partial responses (PR) at the last observation date. Five patients underwent splenectomy, and four of them had complete responses (CR) and the remaining patient had a (PR). Four patients received eradication of Helicobactor pylori (H. pylori) infection, and all patients had CRs. Therefore, the ITP patients with HTLV-I infection should receive eradication therapy in the case of H. pylori infection as the first step of therapy and the splenectomy should be considered, if there is no response to conventional therapy. Human immunodeficiency virus (HIV) causes thrombocytopenia in 10% of patients with active HIV disease. The etiologies of HIV thrombocytopenia are considered as follows, the escalated destruction of platelets by the immune system, damage to megakaryocytes by HIV infection and the inhibition of thrombopoiesis by some anti-viral drugs. In the case of ITP patients with HTLV-I infection, the main etiology may be the increased destruction of platelets by immune system. The proviral load and the integration pattern of HTLV-I should be examined to clarify the stage of HTLV-I infection. The possibility of infection of the megakaryocytes by HTLV-I should be also examined for etiological approach.
Collapse
Affiliation(s)
- Kakushi Matsushita
- The First Department of Internal Medicine, Faculty of Medicine, Kagoshima University, Sakuragaoka, Kagoshima, Japan.
| | | | | | | |
Collapse
|
23
|
Miyata M, Hamasaki S, Tei C. Gender specific effects of valsartan on fibrinolysis in hypertensive patients with metabolic syndrome. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht311.5964] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
24
|
Yoshino S, Minagoe S, Yu B, Kosedo I, Yamashita M, Ishizawa M, Kono M, Setoguchi M, Nakashima H, Matsuoka T, Suehiro S, Yotsumoto G, Yamashita M, Tei C. Cardiac tamponade due to rupture of coronary artery fistula to the coronary sinus with giant aneurysm of coronary artery: usefulness of transthoracic echocardiography. Heart Vessels 2012; 28:536-40. [PMID: 23124933 DOI: 10.1007/s00380-012-0279-9] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/08/2012] [Accepted: 08/10/2012] [Indexed: 01/08/2023]
Abstract
A 68-year-old woman was admitted to our hospital because of back pain and syncope. Transthoracic echocardiography revealed pericardial effusion, a collapsed right ventricle, a giant aneurysm connected to the coronary sinus, a dilated left main trunk coronary artery, and a dilated left circumflex artery (LCx). Furthermore, there was a coronary artery fistula arising from the LCx that drained into the coronary sinus. We diagnosed cardiac tamponade due to rupture of the coronary artery fistula or giant aneurysm, and successful emergency surgery was performed. Rupture of coronary artery aneurysm or coronary artery fistula is very rare. Transthoracic two-dimensional echocardiography was very useful in our case for the diagnosis of cardiac tamponade, giant coronary aneurysm, and coronary artery fistula.
Collapse
Affiliation(s)
- Satoshi Yoshino
- The First Division of Cardiology, National Hospital Organization Kagoshima Medical Center, 8-1 Shiroyama, Kagoshima, 892-0853, Japan
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Miyata M, Kubozono T, Shinsato T, Tei C. Nobel Cardiac Rehabilitation: Waon Therapy. J Card Fail 2012. [DOI: 10.1016/j.cardfail.2012.08.106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
26
|
Shinsato T, Miyata M, Kubozono T, Kawazoe S, Hamasaki S, Tei C. Effect of Waon Therapy on Heart Failure: Analysis in 296 Patients with Chronic Heart Failure. J Card Fail 2012. [DOI: 10.1016/j.cardfail.2012.08.219] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
27
|
Furusho Y, Miyata M, Matsuyama T, Nagai T, Li H, Akasaki Y, Hamada N, Miyauchi T, Ikeda Y, Shirasawa T, Ide K, Tei C. Novel Therapy for Atherosclerosis Using Recombinant Immunotoxin Against Folate Receptor β-Expressing Macrophages. J Am Heart Assoc 2012; 1:e003079. [PMID: 23130174 PMCID: PMC3487340 DOI: 10.1161/jaha.112.003079] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/09/2012] [Accepted: 06/19/2012] [Indexed: 12/02/2022]
Abstract
Background Folate receptor β (FRβ) is induced during macrophage activation. A recombinant immunotoxin consisting of the truncated Pseudomonas exotoxin A (PE38) conjugated to an anti-FRβ antibody (anti–FRβ-PE38) has been reported to kill activated macrophages in inflammatory diseases. To elucidate the effect of an immunotoxin targeting FRβ on atherosclerosis, we determined the presence of FRβ-expressing macrophages in atherosclerotic lesions and administered the FRβ immunotoxin in apolipoprotein E–deficient mice. Methods and Results The FRβ-expressing macrophages were observed in atherosclerotic lesions of apolipoprotein E–deficient mice. At 15 or 35 weeks of age, the apolipoprotein E–deficient mice were divided into 3 groups and were intravenously administered 0.1 mg/kg of anti–FRβ-PE38 (immunotoxin group), 0.1 mg/kg of PE38 (toxin group), or 0.1 mL of saline (control group) every 3 days, for a total of 5 times for each age group. The mice were analyzed at 21 or 41 weeks of age. Treatment with the immunotoxin resulted in 31% and 22% reductions in atherosclerotic lesions of the 21- and 41-week-old mice, respectively (P<0.05). Administration of immunotoxin reduced the numbers of FRβ- and tumor necrosis factor-α–expressing macrophages, reduced cell proliferation, and increased the number of apoptotic cells (P<0.05). Real-time polymerase chain reaction demonstrated that the expression of FRβ and tumor necrosis factor-α mRNA was significantly decreased in the immunotoxin group (P<0.05). Conclusions These results suggest that FRβ-expressing macrophages exist in the atherosclerotic lesions of apolipoprotein E–deficient mice and that FRβ immunotoxin administration reduces the progression of atherosclerotic lesions in younger and older individuals. The recombinant FRβ immunotoxin targeting activated macrophages could provide a novel therapeutic tool for atherosclerosis. (J Am Heart Assoc. 2012;1:e003079 doi: 10.1161/JAHA.112.003079.)
Collapse
Affiliation(s)
- Yuko Furusho
- Department of Cardiovascular, Respiratory, and Metabolic Medicine, Kagoshima University, Kagoshima, Japan (Y.F., M.M., Y.A., N.H., T. Miyauchi, Y.I., T.S., K.I., C.T.)
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
28
|
Maenosono R, Oketani N, Ishida S, Iriki Y, Ichiki H, Okui H, Ninomiya Y, Hamasaki S, Namino F, Matsushita M, Tei C, Hashiguchi T. Effectiveness of esophagus detection by three-dimensional electroanatomical mapping to avoid esophageal injury during ablation of atrial fibrillation. J Cardiol 2012; 60:119-25. [DOI: 10.1016/j.jjcc.2012.02.009] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/13/2012] [Revised: 02/27/2012] [Accepted: 02/29/2012] [Indexed: 11/30/2022]
|
29
|
Miyata M, Ikeda Y, Nakamura S, Sasaki T, Abe S, Minagoe S, Torii H, Lee S, Tateishi S, Kihara K, Ohba I, Kajiya S, Furusho Y, Hamasaki S, Tei C. Effects of valsartan on fibrinolysis in hypertensive patients with metabolic syndrome. Circ J 2012; 76:843-51. [PMID: 22451451 DOI: 10.1253/circj.cj-12-0153] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
BACKGROUND The purpose of this study was to analyze the effect of valsartan on abnormal adipocyte metabolism and prothrombotic state in hypertensive patients with metabolic syndrome (MetS). METHODS AND RESULTS We conducted a multicenter, prospective, randomized, parallel-group controlled trial in 150 hypertensive patients with MetS. They were randomly assigned to receive either 80-160 mg valsartan per day (valsartan group, n=79) or other conventional treatment without a renin-angiotensin system (RAS) inhibitor (non-RAS inhibitor group, n=71). After 1 year, there were no significant differences between the 2 groups in the changes in systolic and diastolic blood pressures (valsartan: 153±15/86±15 to 138±16/77±12 mmHg; non-RAS inhibitor: 150±14/82±15 to 137±15/76±10 mmHg). There was a significant difference in the change in the levels of plasminogen activator inhibitor-1 (PAI-1) between the 2 groups after 1 year (valsartan: 3.7±3.2 ng/ml; non-RAS inhibitor: 5.8±3.3 ng/ml, P=0.04). There was no significant difference between groups in the change in the concentration of adiponectin after 1 year (valsartan: 0.3±0.4 µg/ml; non-RAS inhibitor: 0.9±0.4 µg/ml, P=0.22). The animal study showed aortic PAI-1 protein expression was reduced in double knockout mice of angiotensin II type 1a receptor and apolipoprotein E (apoE) compared with the apoE knockout mice. CONCLUSIONS Valsartan reduced plasma PAI-1 levels compared to non-RAS inhibitor in hypertensive patients with MetS, which suggests it may be useful for improving fibrinolytic function.
Collapse
Affiliation(s)
- Masaaki Miyata
- Department of Cardiovascular, Respiratory and Metabolic Medicine, Graduate School of Medicine, Kagoshima University, Japan
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
30
|
Miyata M, Sasaki T, Ikeda Y, Shinsato T, Kubozono T, Furusho Y, Kusumoto A, Hamasaki S, Tei C. Comparative study of therapeutic effects of short- and long-acting loop diuretics in outpatients with chronic heart failure (COLD-CHF). J Cardiol 2012; 59:352-8. [DOI: 10.1016/j.jjcc.2011.12.007] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/23/2011] [Revised: 12/07/2011] [Accepted: 12/28/2011] [Indexed: 12/22/2022]
|
31
|
Miyauchi T, Miyata M, Ikeda Y, Akasaki Y, Hamada N, Shirasawa T, Furusho Y, Tei C. Waon therapy upregulates Hsp90 and leads to angiogenesis through the Akt-endothelial nitric oxide synthase pathway in mouse hindlimb ischemia. Circ J 2012; 76:1712-21. [PMID: 22481103 DOI: 10.1253/circj.cj-11-0915] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
BACKGROUND Thermal therapy, namely Waon therapy, has previously been reported to regulate nitric oxide (NO) and endothelial NO synthase (eNOS) and augment ischemia-induced angiogenesis in mice and improve limb ischemia in patients with peripheral artery disease. The aim of this study was to clarify the precise mechanism by which Waon therapy augments angiogenesis in mice with hindlimb ischemia. METHODS AND RESULTS Unilateral hindlimb ischemia was induced in apolipoprotein E-deficient mice and Waon therapy was performed for 5 weeks. Heat shock protein 90 (Hsp90), phosphorylated-Akt, and phosphorylated-eNOS were detected in arterial endothelial cells of ischemic hindlimbs and all were upregulated by Waon therapy compared to controls. Waon therapy also increased serum concentrations of nitrite and nitrate. Capillary density and the ischemic limb/normal side blood perfusion ratio monitored by laser Doppler perfusion imaging in the Waon therapy group were significantly increased beyond those in the control group. The effect of Waon therapy on angiogenesis through the activation of the Hsp90/Akt/eNOS pathway was attenuated by the administration of a Hsp90 inhibitor. CONCLUSIONS It is suggested that Waon therapy upregulates Hsp90, which contributes to the activation of the Akt/eNOS/NO pathway, and induces angiogenesis in mice with hindlimb ischemia.
Collapse
Affiliation(s)
- Takahiro Miyauchi
- Department of Cardiovascular, Respiratory and Metabolic Medicine, Graduate School of Medicine, Kagoshima University, Kagoshima, Japan
| | | | | | | | | | | | | | | |
Collapse
|
32
|
Tokushige A, Shiomi H, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Iwabuchi M, Shizuta S, Tada T, Tazaki J, Kato Y, Hayano M, Abe M, Ehara N, Inada T, Kaburagi S, Hamasaki S, Tei C, Nakashima H, Ogawa H, Tatami R, Suwa S, Takizawa A, Nohara R, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T. Incidence and Outcome of Surgical Procedures After Coronary Bare-Metal and Drug-Eluting Stent Implantation. Circ Cardiovasc Interv 2012; 5:237-46. [DOI: 10.1161/circinterventions.111.963728] [Citation(s) in RCA: 37] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Background—
There still remain safety concerns on surgical procedures after coronary drug-eluting stents (DES) implantation, and optimal management of perioperative antiplatelet therapy (APT) has not been yet established.
Methods and Results—
During 3-year follow-up of 12 207 patients (DES=6802 patients and bare-metal stent [BMS] only=5405 patients) who underwent coronary stent implantation in the CREDO-Kyoto registry cohort-2, surgical procedures were performed in 2398 patients (DES=1295 patients and BMS=1103 patients). Surgical procedures (early surgery in particular) were more frequently performed in the BMS group than in the DES group (4.4% versus 1.9% at 42-day and 23% versus 21% at 3-year, log-rank
P
=0.0007). Cumulative incidences of death/myocardial infarction (MI)/stent thrombosis (ST) and bleeding at 30 days after surgery were low, without differences between BMS and DES (3.5% versus 2.9%,
P
=0.4 and 3.2% versus 2.1%,
P
=0.2, respectively). The adjusted risks of DES use relative to BMS use for death/MI/ST and bleeding were not significant (hazard ratio: 1.63, 95% confidence interval: 0.93 to 2.87,
P
=0.09 and hazard ratio: 0.6, 95% confidence interval: 0.34 to 1.06,
P
=0.08, respectively). The risks of perioperative single- and no-APT relative to dual-APT for both death/MI/ST and bleeding were not significant; single-APT as compared with dual-APT tended to be associated with lower risk for death/MI/ST (hazard ratio: 0.4, 95% confidence interval: 0.13 to 1.01,
P
=0.053).
Conclusions—
Surgical procedures were commonly performed after coronary stent implantation, and the risk of ischemic and bleeding complications in surgical procedures was low. In patients selected to receive DES or BMS, there were no differences in outcomes. Perioperative administration of dual-APT was not associated with lower risk for ischemic events.
Collapse
Affiliation(s)
- Akihiro Tokushige
- From the Department of Cardiovascular Medicine (A.T., H.S., S.S., T.T., J.T., Y.K., M.H., T.K.), Graduate School of Medicine, Kyoto University; Center for Medical Education and Clinical Epidemiology Unit (T.M.), Graduate School of Medicine, Kyoto University, Department of Cardiovascular Medicine (Y.F., N.E., T.K.), Kobe City Medical Center General Hospital; Division of Cardiology (Y.N.), Tenri Hospital; Division of Cardiology (K.K., K.M.), Kurashiki Central Hospital; Division of Cardiology (M.I., M
| | - Hiroki Shiomi
- From the Department of Cardiovascular Medicine (A.T., H.S., S.S., T.T., J.T., Y.K., M.H., T.K.), Graduate School of Medicine, Kyoto University; Center for Medical Education and Clinical Epidemiology Unit (T.M.), Graduate School of Medicine, Kyoto University, Department of Cardiovascular Medicine (Y.F., N.E., T.K.), Kobe City Medical Center General Hospital; Division of Cardiology (Y.N.), Tenri Hospital; Division of Cardiology (K.K., K.M.), Kurashiki Central Hospital; Division of Cardiology (M.I., M
| | - Takeshi Morimoto
- From the Department of Cardiovascular Medicine (A.T., H.S., S.S., T.T., J.T., Y.K., M.H., T.K.), Graduate School of Medicine, Kyoto University; Center for Medical Education and Clinical Epidemiology Unit (T.M.), Graduate School of Medicine, Kyoto University, Department of Cardiovascular Medicine (Y.F., N.E., T.K.), Kobe City Medical Center General Hospital; Division of Cardiology (Y.N.), Tenri Hospital; Division of Cardiology (K.K., K.M.), Kurashiki Central Hospital; Division of Cardiology (M.I., M
| | - Yutaka Furukawa
- From the Department of Cardiovascular Medicine (A.T., H.S., S.S., T.T., J.T., Y.K., M.H., T.K.), Graduate School of Medicine, Kyoto University; Center for Medical Education and Clinical Epidemiology Unit (T.M.), Graduate School of Medicine, Kyoto University, Department of Cardiovascular Medicine (Y.F., N.E., T.K.), Kobe City Medical Center General Hospital; Division of Cardiology (Y.N.), Tenri Hospital; Division of Cardiology (K.K., K.M.), Kurashiki Central Hospital; Division of Cardiology (M.I., M
| | - Yoshihisa Nakagawa
- From the Department of Cardiovascular Medicine (A.T., H.S., S.S., T.T., J.T., Y.K., M.H., T.K.), Graduate School of Medicine, Kyoto University; Center for Medical Education and Clinical Epidemiology Unit (T.M.), Graduate School of Medicine, Kyoto University, Department of Cardiovascular Medicine (Y.F., N.E., T.K.), Kobe City Medical Center General Hospital; Division of Cardiology (Y.N.), Tenri Hospital; Division of Cardiology (K.K., K.M.), Kurashiki Central Hospital; Division of Cardiology (M.I., M
| | - Kazushige Kadota
- From the Department of Cardiovascular Medicine (A.T., H.S., S.S., T.T., J.T., Y.K., M.H., T.K.), Graduate School of Medicine, Kyoto University; Center for Medical Education and Clinical Epidemiology Unit (T.M.), Graduate School of Medicine, Kyoto University, Department of Cardiovascular Medicine (Y.F., N.E., T.K.), Kobe City Medical Center General Hospital; Division of Cardiology (Y.N.), Tenri Hospital; Division of Cardiology (K.K., K.M.), Kurashiki Central Hospital; Division of Cardiology (M.I., M
| | - Masashi Iwabuchi
- From the Department of Cardiovascular Medicine (A.T., H.S., S.S., T.T., J.T., Y.K., M.H., T.K.), Graduate School of Medicine, Kyoto University; Center for Medical Education and Clinical Epidemiology Unit (T.M.), Graduate School of Medicine, Kyoto University, Department of Cardiovascular Medicine (Y.F., N.E., T.K.), Kobe City Medical Center General Hospital; Division of Cardiology (Y.N.), Tenri Hospital; Division of Cardiology (K.K., K.M.), Kurashiki Central Hospital; Division of Cardiology (M.I., M
| | - Satoshi Shizuta
- From the Department of Cardiovascular Medicine (A.T., H.S., S.S., T.T., J.T., Y.K., M.H., T.K.), Graduate School of Medicine, Kyoto University; Center for Medical Education and Clinical Epidemiology Unit (T.M.), Graduate School of Medicine, Kyoto University, Department of Cardiovascular Medicine (Y.F., N.E., T.K.), Kobe City Medical Center General Hospital; Division of Cardiology (Y.N.), Tenri Hospital; Division of Cardiology (K.K., K.M.), Kurashiki Central Hospital; Division of Cardiology (M.I., M
| | - Tomohisa Tada
- From the Department of Cardiovascular Medicine (A.T., H.S., S.S., T.T., J.T., Y.K., M.H., T.K.), Graduate School of Medicine, Kyoto University; Center for Medical Education and Clinical Epidemiology Unit (T.M.), Graduate School of Medicine, Kyoto University, Department of Cardiovascular Medicine (Y.F., N.E., T.K.), Kobe City Medical Center General Hospital; Division of Cardiology (Y.N.), Tenri Hospital; Division of Cardiology (K.K., K.M.), Kurashiki Central Hospital; Division of Cardiology (M.I., M
| | - Junichi Tazaki
- From the Department of Cardiovascular Medicine (A.T., H.S., S.S., T.T., J.T., Y.K., M.H., T.K.), Graduate School of Medicine, Kyoto University; Center for Medical Education and Clinical Epidemiology Unit (T.M.), Graduate School of Medicine, Kyoto University, Department of Cardiovascular Medicine (Y.F., N.E., T.K.), Kobe City Medical Center General Hospital; Division of Cardiology (Y.N.), Tenri Hospital; Division of Cardiology (K.K., K.M.), Kurashiki Central Hospital; Division of Cardiology (M.I., M
| | - Yoshihiro Kato
- From the Department of Cardiovascular Medicine (A.T., H.S., S.S., T.T., J.T., Y.K., M.H., T.K.), Graduate School of Medicine, Kyoto University; Center for Medical Education and Clinical Epidemiology Unit (T.M.), Graduate School of Medicine, Kyoto University, Department of Cardiovascular Medicine (Y.F., N.E., T.K.), Kobe City Medical Center General Hospital; Division of Cardiology (Y.N.), Tenri Hospital; Division of Cardiology (K.K., K.M.), Kurashiki Central Hospital; Division of Cardiology (M.I., M
| | - Mamoru Hayano
- From the Department of Cardiovascular Medicine (A.T., H.S., S.S., T.T., J.T., Y.K., M.H., T.K.), Graduate School of Medicine, Kyoto University; Center for Medical Education and Clinical Epidemiology Unit (T.M.), Graduate School of Medicine, Kyoto University, Department of Cardiovascular Medicine (Y.F., N.E., T.K.), Kobe City Medical Center General Hospital; Division of Cardiology (Y.N.), Tenri Hospital; Division of Cardiology (K.K., K.M.), Kurashiki Central Hospital; Division of Cardiology (M.I., M
| | - Mitsuru Abe
- From the Department of Cardiovascular Medicine (A.T., H.S., S.S., T.T., J.T., Y.K., M.H., T.K.), Graduate School of Medicine, Kyoto University; Center for Medical Education and Clinical Epidemiology Unit (T.M.), Graduate School of Medicine, Kyoto University, Department of Cardiovascular Medicine (Y.F., N.E., T.K.), Kobe City Medical Center General Hospital; Division of Cardiology (Y.N.), Tenri Hospital; Division of Cardiology (K.K., K.M.), Kurashiki Central Hospital; Division of Cardiology (M.I., M
| | - Natsuhiko Ehara
- From the Department of Cardiovascular Medicine (A.T., H.S., S.S., T.T., J.T., Y.K., M.H., T.K.), Graduate School of Medicine, Kyoto University; Center for Medical Education and Clinical Epidemiology Unit (T.M.), Graduate School of Medicine, Kyoto University, Department of Cardiovascular Medicine (Y.F., N.E., T.K.), Kobe City Medical Center General Hospital; Division of Cardiology (Y.N.), Tenri Hospital; Division of Cardiology (K.K., K.M.), Kurashiki Central Hospital; Division of Cardiology (M.I., M
| | - Tsukasa Inada
- From the Department of Cardiovascular Medicine (A.T., H.S., S.S., T.T., J.T., Y.K., M.H., T.K.), Graduate School of Medicine, Kyoto University; Center for Medical Education and Clinical Epidemiology Unit (T.M.), Graduate School of Medicine, Kyoto University, Department of Cardiovascular Medicine (Y.F., N.E., T.K.), Kobe City Medical Center General Hospital; Division of Cardiology (Y.N.), Tenri Hospital; Division of Cardiology (K.K., K.M.), Kurashiki Central Hospital; Division of Cardiology (M.I., M
| | - Satoshi Kaburagi
- From the Department of Cardiovascular Medicine (A.T., H.S., S.S., T.T., J.T., Y.K., M.H., T.K.), Graduate School of Medicine, Kyoto University; Center for Medical Education and Clinical Epidemiology Unit (T.M.), Graduate School of Medicine, Kyoto University, Department of Cardiovascular Medicine (Y.F., N.E., T.K.), Kobe City Medical Center General Hospital; Division of Cardiology (Y.N.), Tenri Hospital; Division of Cardiology (K.K., K.M.), Kurashiki Central Hospital; Division of Cardiology (M.I., M
| | - Shuichi Hamasaki
- From the Department of Cardiovascular Medicine (A.T., H.S., S.S., T.T., J.T., Y.K., M.H., T.K.), Graduate School of Medicine, Kyoto University; Center for Medical Education and Clinical Epidemiology Unit (T.M.), Graduate School of Medicine, Kyoto University, Department of Cardiovascular Medicine (Y.F., N.E., T.K.), Kobe City Medical Center General Hospital; Division of Cardiology (Y.N.), Tenri Hospital; Division of Cardiology (K.K., K.M.), Kurashiki Central Hospital; Division of Cardiology (M.I., M
| | - Chuwa Tei
- From the Department of Cardiovascular Medicine (A.T., H.S., S.S., T.T., J.T., Y.K., M.H., T.K.), Graduate School of Medicine, Kyoto University; Center for Medical Education and Clinical Epidemiology Unit (T.M.), Graduate School of Medicine, Kyoto University, Department of Cardiovascular Medicine (Y.F., N.E., T.K.), Kobe City Medical Center General Hospital; Division of Cardiology (Y.N.), Tenri Hospital; Division of Cardiology (K.K., K.M.), Kurashiki Central Hospital; Division of Cardiology (M.I., M
| | - Hitoshi Nakashima
- From the Department of Cardiovascular Medicine (A.T., H.S., S.S., T.T., J.T., Y.K., M.H., T.K.), Graduate School of Medicine, Kyoto University; Center for Medical Education and Clinical Epidemiology Unit (T.M.), Graduate School of Medicine, Kyoto University, Department of Cardiovascular Medicine (Y.F., N.E., T.K.), Kobe City Medical Center General Hospital; Division of Cardiology (Y.N.), Tenri Hospital; Division of Cardiology (K.K., K.M.), Kurashiki Central Hospital; Division of Cardiology (M.I., M
| | - Hisao Ogawa
- From the Department of Cardiovascular Medicine (A.T., H.S., S.S., T.T., J.T., Y.K., M.H., T.K.), Graduate School of Medicine, Kyoto University; Center for Medical Education and Clinical Epidemiology Unit (T.M.), Graduate School of Medicine, Kyoto University, Department of Cardiovascular Medicine (Y.F., N.E., T.K.), Kobe City Medical Center General Hospital; Division of Cardiology (Y.N.), Tenri Hospital; Division of Cardiology (K.K., K.M.), Kurashiki Central Hospital; Division of Cardiology (M.I., M
| | - Ryozo Tatami
- From the Department of Cardiovascular Medicine (A.T., H.S., S.S., T.T., J.T., Y.K., M.H., T.K.), Graduate School of Medicine, Kyoto University; Center for Medical Education and Clinical Epidemiology Unit (T.M.), Graduate School of Medicine, Kyoto University, Department of Cardiovascular Medicine (Y.F., N.E., T.K.), Kobe City Medical Center General Hospital; Division of Cardiology (Y.N.), Tenri Hospital; Division of Cardiology (K.K., K.M.), Kurashiki Central Hospital; Division of Cardiology (M.I., M
| | - Satoru Suwa
- From the Department of Cardiovascular Medicine (A.T., H.S., S.S., T.T., J.T., Y.K., M.H., T.K.), Graduate School of Medicine, Kyoto University; Center for Medical Education and Clinical Epidemiology Unit (T.M.), Graduate School of Medicine, Kyoto University, Department of Cardiovascular Medicine (Y.F., N.E., T.K.), Kobe City Medical Center General Hospital; Division of Cardiology (Y.N.), Tenri Hospital; Division of Cardiology (K.K., K.M.), Kurashiki Central Hospital; Division of Cardiology (M.I., M
| | - Akinori Takizawa
- From the Department of Cardiovascular Medicine (A.T., H.S., S.S., T.T., J.T., Y.K., M.H., T.K.), Graduate School of Medicine, Kyoto University; Center for Medical Education and Clinical Epidemiology Unit (T.M.), Graduate School of Medicine, Kyoto University, Department of Cardiovascular Medicine (Y.F., N.E., T.K.), Kobe City Medical Center General Hospital; Division of Cardiology (Y.N.), Tenri Hospital; Division of Cardiology (K.K., K.M.), Kurashiki Central Hospital; Division of Cardiology (M.I., M
| | - Ryuji Nohara
- From the Department of Cardiovascular Medicine (A.T., H.S., S.S., T.T., J.T., Y.K., M.H., T.K.), Graduate School of Medicine, Kyoto University; Center for Medical Education and Clinical Epidemiology Unit (T.M.), Graduate School of Medicine, Kyoto University, Department of Cardiovascular Medicine (Y.F., N.E., T.K.), Kobe City Medical Center General Hospital; Division of Cardiology (Y.N.), Tenri Hospital; Division of Cardiology (K.K., K.M.), Kurashiki Central Hospital; Division of Cardiology (M.I., M
| | - Hisayoshi Fujiwara
- From the Department of Cardiovascular Medicine (A.T., H.S., S.S., T.T., J.T., Y.K., M.H., T.K.), Graduate School of Medicine, Kyoto University; Center for Medical Education and Clinical Epidemiology Unit (T.M.), Graduate School of Medicine, Kyoto University, Department of Cardiovascular Medicine (Y.F., N.E., T.K.), Kobe City Medical Center General Hospital; Division of Cardiology (Y.N.), Tenri Hospital; Division of Cardiology (K.K., K.M.), Kurashiki Central Hospital; Division of Cardiology (M.I., M
| | - Kazuaki Mitsudo
- From the Department of Cardiovascular Medicine (A.T., H.S., S.S., T.T., J.T., Y.K., M.H., T.K.), Graduate School of Medicine, Kyoto University; Center for Medical Education and Clinical Epidemiology Unit (T.M.), Graduate School of Medicine, Kyoto University, Department of Cardiovascular Medicine (Y.F., N.E., T.K.), Kobe City Medical Center General Hospital; Division of Cardiology (Y.N.), Tenri Hospital; Division of Cardiology (K.K., K.M.), Kurashiki Central Hospital; Division of Cardiology (M.I., M
| | - Masakiyo Nobuyoshi
- From the Department of Cardiovascular Medicine (A.T., H.S., S.S., T.T., J.T., Y.K., M.H., T.K.), Graduate School of Medicine, Kyoto University; Center for Medical Education and Clinical Epidemiology Unit (T.M.), Graduate School of Medicine, Kyoto University, Department of Cardiovascular Medicine (Y.F., N.E., T.K.), Kobe City Medical Center General Hospital; Division of Cardiology (Y.N.), Tenri Hospital; Division of Cardiology (K.K., K.M.), Kurashiki Central Hospital; Division of Cardiology (M.I., M
| | - Toru Kita
- From the Department of Cardiovascular Medicine (A.T., H.S., S.S., T.T., J.T., Y.K., M.H., T.K.), Graduate School of Medicine, Kyoto University; Center for Medical Education and Clinical Epidemiology Unit (T.M.), Graduate School of Medicine, Kyoto University, Department of Cardiovascular Medicine (Y.F., N.E., T.K.), Kobe City Medical Center General Hospital; Division of Cardiology (Y.N.), Tenri Hospital; Division of Cardiology (K.K., K.M.), Kurashiki Central Hospital; Division of Cardiology (M.I., M
| | - Takeshi Kimura
- From the Department of Cardiovascular Medicine (A.T., H.S., S.S., T.T., J.T., Y.K., M.H., T.K.), Graduate School of Medicine, Kyoto University; Center for Medical Education and Clinical Epidemiology Unit (T.M.), Graduate School of Medicine, Kyoto University, Department of Cardiovascular Medicine (Y.F., N.E., T.K.), Kobe City Medical Center General Hospital; Division of Cardiology (Y.N.), Tenri Hospital; Division of Cardiology (K.K., K.M.), Kurashiki Central Hospital; Division of Cardiology (M.I., M
| |
Collapse
|
33
|
Yoshino S, Hamasaki S, Ishida S, Kataoka T, Yoshikawa A, Oketani N, Saihara K, Ichiki H, Kuwahata S, Fujita S, Takumi T, Yoshimoto I, Nakazaki M, Tei C. Characterization of the effect of serum bilirubin concentrations on coronary endothelial function via measurement of high-sensitivity C-reactive protein and high-density lipoprotein cholesterol. Heart Vessels 2012; 28:157-65. [PMID: 22457095 DOI: 10.1007/s00380-011-0228-z] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/31/2011] [Accepted: 12/25/2011] [Indexed: 12/01/2022]
Abstract
Bilirubin can prevent oxidation of low-density lipoprotein (LDL) and may protect against atherosclerosis and coronary heart disease (CHD). The goal of this study was to characterize the relationship between bilirubin and CHD through measurements of bilirubin concentration, coronary endothelial function, and markers of oxidative stress, inflammation, and lipid/glucose metabolism. The study population consisted of 141 patients without CHD who underwent Doppler flow study. Vascular reactivity was examined by intracoronary administration of papaverine, acetylcholine (ACh) and nitroglycerin using a Doppler guide wire. Serum bilirubin, high-sensitivity C-reactive protein (hsCRP), malondialdehyde-modified LDL, LDL cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), fasting plasma glucose (FPG), and immunoreactive insulin were also measured. Homeostasis model assessment insulin resistance index and estimated glomerular filtration rate (eGFR) were calculated. Univariate analysis revealed that both percent change in coronary blood flow (CBF) and coronary artery diameter induced by ACh correlated positively with log-transformed bilirubin (r = 0.22, P < 0.05; r = 0.20, P < 0.05, respectively). Percent change in CBF in response to ACh correlated positively with eGFR (r = 0.24, P < 0.05) and correlated inversely with age, LDL-C, and log-transformed FPG (r = -0.24, P < 0.05; r = -0.17, P < 0.05, r = -0.22, P < 0.05, respectively). Multivariate analysis revealed that log-transformed bilirubin was the only independent predictor of percent change in CBF in response to ACh. Multivariate analysis revealed that log-transformed hsCRP and HDL-C were independent predictors of log-transformed bilirubin. These results suggest that a high level of bilirubin is associated with favorable coronary endothelial function, which may be mediated via the effect of bilirubin on inflammation and HDL-C.
Collapse
Affiliation(s)
- Satoshi Yoshino
- Department of Cardiovascular, Respiratory and Metabolic Medicine, Graduate School of Medicine, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima, 890-8520, Japan
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
34
|
Takasaki K, Miyata M, Imamura M, Yuasa T, Kuwahara E, Kubota K, Kono M, Ueya N, Horizoe Y, Chaen H, Mizukami N, Kisanuki A, Hamasaki S, Tei C. Left ventricular dysfunction assessed by cardiac time interval analysis among different geometric patterns in untreated hypertension. Circ J 2012; 76:1409-14. [PMID: 22447013 DOI: 10.1253/circj.cj-11-1369] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
BACKGROUND Left ventricular (LV) hypertrophy is a powerful independent predictor of morbidity and mortality in hypertensive patients. Abnormal LV geometric patterns are also associated with hypertensive complications, and concentric hypertrophy is associated with the highest mortality in hypertensive patients. However, the relationship between geometric patterns and cardiac dysfunction is not fully established. We hypothesized that the Tei index, which is a measure of global cardiac function, is a feasible parameter for estimating cardiac dysfunction among the different LV geometric patterns in hypertensive patients. METHODS AND RESULTS We enrolled 60 consecutive patients with untreated essential hypertension. Subjects were divided into 4 groups: normal geometry, concentric remodeling, eccentric hypertrophy and concentric hypertrophy. We measured ejection fraction, mitral E/A ratio, Tei index, ejection time, and isovolumic contraction and relaxation times. There were significant correlations between LV mass index and systolic blood pressure (P<0.01), ejection fraction (P<0.05), mitral E/A ratio (P<0.05) and Tei index (P<0.0001). In multiple regression analysis, only the Tei index independently correlated with LV mass index (P<0.01). Concentric hypertrophy significantly increased the Tei index compared with the other 3 groups. CONCLUSIONS The Tei index provides a better marker for LV dysfunction by hypertensive hypertrophy than conventional parameters. LV function in concentric hypertrophy was most impaired among all the geometric patterns in untreated hypertensive patients.
Collapse
Affiliation(s)
- Kunitsugu Takasaki
- Department of Cardiovascular, Respiratory and Metabolic Medicine, Graduate School of Medicine, Kagoshima University, Kagoshima, Japan
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
35
|
Otsuji Y, Kisanuki A, Minagoe S, Tei C. Evidence for impaired left ventricular ejection in hypertrophic obstructive cardiomyopathy: dynamic aortic ejection flow velocity profile demonstrated by pulsed Doppler echocardiography. J Echocardiogr 2012; 10:32-4. [PMID: 27277929 DOI: 10.1007/s12574-012-0109-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2011] [Accepted: 01/09/2012] [Indexed: 11/28/2022]
Affiliation(s)
- Yutaka Otsuji
- Second Department of Internal Medicine, University of Occupational and Environmental Health, School of Medicine, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu, 807-8555, Japan.
| | - Akira Kisanuki
- Department of Cardiovascular Medicine, Kagoshima University, Kagoshima, Japan
| | - Shinichi Minagoe
- Department of Cardiology, National Hospital Organization Kagoshima Medical Center, Kagoshima, Japan
| | - Chuwa Tei
- Department of Cardiovascular Medicine, Kagoshima University, Kagoshima, Japan
| |
Collapse
|
36
|
Ichiki H, Oketani N, Ishida S, Iriki Y, Okui H, Maenosono R, Ninomiya Y, Matsushita T, Miyata M, Hamasaki S, Tei C. Incidence of Asymptomatic Cerebral Microthromboembolism After Atrial Fibrillation Ablation Guided by Complex Fractionated Atrial Electrogram. J Cardiovasc Electrophysiol 2012; 23:567-73. [PMID: 22313240 DOI: 10.1111/j.1540-8167.2011.02259.x] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Hitoshi Ichiki
- Department of Cardiovascular, Respiratory and Metabolic Medicine, Graduate School of Medicine, Kagoshima University, Kagoshima, Japan
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Ikeda Y, Miyata M, Akasaki Y, Miyauchi T, Furusho Y, Ide K, Hamasaki S, Tei C. Abstract P323: Waon Therapy, a Form of Thermal Therapy, Reduces Oxidative Stress Systemically and Inhibits the Progression of Cardiac Dysfunction in TO-2 Cardiomyopathic Hamsters with Heart Failure. Circ Res 2011. [DOI: 10.1161/res.109.suppl_1.ap323] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Background:
Oxidative stress is one of the most crucial factors that develop chronic heart failure (CHF), leading to cardiac apoptosis and fibrosis and vascular endothelial dysfunction. We have reported that Waon therapy, which is a form of thermal therapy using a far infrared-ray dry sauna at 60 degrees centigrade, improves cardiac and vascular endothelial functions and prognosis in patients with CHF. The aim of this study is to investigate whether Waon therapy reduces oxidative stress and prevents from developing cardiac dysfunction in CHF.
Methods:
Thirty-week old male TO-2 cardiomyopathic hamsters with CHF were divided into Waon therapy or control group. Waon therapy group underwent Waon therapy daily for 4 weeks. Control hamsters did not take any treatment. We examined the amounts of reactive oxygen species of serum, hearts and aortas using ELISA and immunohistochemistry. We measured left ventricular % fractional shortening (LV%FS), and performed TUNEL and Azan staining of hearts to assess cardiac function, apoptosis and fibrosis, respectively. Anti-oxidants and apoptotic and angiogenetic factors were assessed by Western blot. All examinations were performed after 4 weeks of treatment.
Results:
Four-week Waon therapy significantly decreased oxidative stress of serum, hearts and aortas compared to those of controls. Waon therapy significantly increased LV%FS and decreased cardiac apoptosis and fibrosis (LV%FS, Waon therapy: 23.3±4.3 vs. control: 16.5±4.2%, P<0.01, TUNEL positive nuclei, 22.0±2.6 vs. 49.3±7.2%, P<0.01, % fibrosis, 20.6±5.3 vs. 47.6±4.8%, P<0.01). Waon therapy significantly increased the expressions of manganese superoxide dismutase, heat shock protein 27 (HSP27) and HSP32 of hearts and aortas, which negatively modulate oxidative stress, compared to those of controls. Waon therapy significantly increased endothelial nitric oxide synthase and decreased plasminogen activator inhibitor-1 of aortas. In addition, Waon therapy significantly decreased Bax, cleaved caspase 3 and cytochrome c and increased Bcl-2 and hypoxia-inducible factor-1α of the failing hearts.
Conclusions:
Waon therapy reduces oxidative stress systemically and inhibits the progression of cardiac dysfuntion in TO-2 cardiomyopathic hamsters.
Collapse
Affiliation(s)
| | | | | | | | - Yuko Furusho
- Dept of Cardiovascular Med, Kagoshima city, Japan
| | - Kanako Ide
- Dept of Cardiovascular Med, Kagoshima city, Japan
| | | | - Chuwa Tei
- Dept of Cardiovascular Med, Kagoshima city, Japan
| |
Collapse
|
38
|
Kenny C, Adhya S, Dworakowski R, Brickham B, Maccarthy P, Monaghan M, Guzzo A, Innocenti F, Vicidomini S, Lazzeretti D, Squarciotta S, De Villa E, Donnini C, Bulletti F, Guerrini E, Pini R, Bendjelid K, Viale J, Duperret S, Piriou V, Jacques D, Shahgaldi K, Silva C, Pedro F, Deister L, Brodin LA, Sahlen A, Manouras A, Winter R, Berjeb N, Cimadevilla C, Dreyfus J, Cueff C, Malanca M, Chiampan A, Vahanian A, Messika-Zeitoun D, Muraru D, Peluso D, Dal Bianco L, Beraldo M, Solda' E, Tuveri M, Cucchini U, Al Mamary A, Badano L, Iliceto S, Almuntaser I, King G, Norris S, Daly C, Ellis E, Murphy R, Erdei T, Denes M, Kardos A, Foldesi C, Temesvari A, Lengyel M, Bouzas Mosquera A, Broullon F, Alvarez-Garcia N, Peteiro J, Barge-Caballero G, Lopez-Perez M, Lopez-Sainz A, Castro-Beiras A, Luotolahti M, Luotolahti H, Kantola I, Viikari J, Andersen M, Ersboell M, Bro-Jeppesen J, Gustafsson F, Koeber L, Hassager C, Moller J, Coisne D, Diakov C, Vallet F, Lequeux B, Blouin P, Christiaens L, Esposito R, Santoro A, Schiano Lomoriello V, Raia R, Santoro C, De Simone G, Galderisi M, Sahlen A, Abdula G, Winter R, Kosmala W, Szczepanik-Osadnik H, Przewlocka-Kosmala M, Mysiak A, O' Moore-Sullivan T, Marwick T, Tan YT, Wenzelburger F, Leyva F, Sanderson J, Pichler P, Syeda B, Hoefer P, Zuckermann A, Binder T, Fijalkowski M, Koprowski A, Galaska R, Blaut K, Sworczak K, Rynkiewicz A, Lee S, Kim W, Jung L, Yun H, Song M, Ko J, Khalifa EA, Szymanski P, Lipczynska M, Klisieiwcz A, Hoffman P, Jorge C, Silva Marques J, Robalo Martins S, Calisto C, Mieiro M, Vieira S, Correia M, Carvalho De Sousa J, Almeida A, Nunes Diogo A, Park C, March K, Tillin T, Mayet J, Chaturvedi N, Hughes A, Di Bello V, Giannini C, Delle Donne M, De Sanctis F, Spontoni P, Cucco C, Corciu A, Grigoratos C, Bogazzi F, Balbarini A, Enescu O, Suran B, Florescu M, Cinteza M, Vinereanu D, Higuchi Y, Iwakura K, Okamura A, Date M, Fujii K, Jorge C, Cortez-Dias N, Silva D, Carrilho-Ferreira P, Silva Marques J, Magalhaes A, Ribeiro S, Goncalves S, Fiuza M, Pinto F, Jorge C, Cortez-Dias N, Silva D, Silva Marques J, Carrilho-Ferreira P, Placido R, Bordalo A, Goncalves S, Fiuza M, Pinto F, Grzywocz P, Mizia-Stec K, Chudek J, Gasior Z, Maceira Gonzalez AM, Cosin Sales J, Dalli E, Igual B, Diago J, Aguilar J, Ruvira J, Cimino S, Pedrizzetti G, Tonti G, Canali E, Petronilli V, Boccalini F, Mattatelli A, Hiramoto Y, Iacoboni C, Agati L, Trifunovic D, Ostojic M, Vujisic-Tesic B, Petrovic M, Nedeljkovic I, Banovic M, Boricic-Kostic M, Draganic G, Tesic M, Petrovic M, Gavina C, Lopes R, Lourenco A, Almeida J, Rodrigues J, Pinho P, Zamorano J, Leite-Moreira A, Rocha-Goncalves F, Clavel MA, Capoulade R, Dumesnil J, Mathieu P, Despres JP, Pibarot P, Bull S, Pitcher A, Augustine D, D'arcy J, Karamitsos T, Rai A, Prendergast B, Becher H, Neubauer S, Myerson S, Magne J, Donal E, Davin L, O'connor K, Pirlet C, Rosca M, Szymanski C, Cosyns B, Pierard L, Lancellotti P, Calin A, Rosca M, Popescu B, Beladan C, Enache R, Lupascu L, Sandu C, Lancellotti P, Pierard L, Ginghina C, Kamperidis V, Hadjimiltiadis S, Sianos G, Anastasiadis K, Grosomanidis V, Efthimiadis G, Karvounis H, Parharidis G, Styliadis I, Gonzalez Canovas C, Munoz-Esparza C, Bonaque Gonzalez J, Fernandez A, Salar Alcaraz M, Saura Espin D, Pinar Bermudez E, Oliva-Sandoval M, De La Morena Valenzuela G, Valdes Chavarri M, Dreyfus J, Brochet E, Lepage L, Attias D, Cueff C, Detaint D, Himbert D, Iung B, Vahanian A, Messika-Zeitoun D, Pirat B, Little S, Chang S, Tiller L, Kumar R, Zoghbi W, Lee APW, Hsiung M, Wan S, Wong R, Luo F, Fang F, Xie J, Underwood M, Sun J, Yu C, Jansen R, Tietge W, Sijbrandij K, Cramer M, De Heer L, Kluin J, Chamuleau SAJ, Oliveras Vila T, Ferrer Sistach E, Delgado Ramis L, Lopez Ayerbe J, Vallejo Camazon N, Gual Capllonch F, Garcia Alonso C, Teis Soley A, Ruyra Baliarda X, Bayes Genis A, Negrea S, Alexandrescu C, Bourlon F, Civaia F, Dreyfus G, Paetzold S, Luha O, Hoedl R, Stoschitzky G, Pfeiffer K, Zweiker D, Pieske B, Maier R, Sevilla T, Revilla A, Lopez J, Vilacosta I, Arnold R, Gomez I, San Roman J, Nikcevic G, Djordjevic Dikic A, Djordjevic S, Raspopovic S, Jovanovic V, Kircanski B, Pavlovic S, Milasinovic G, Ruiz-Zamora I, Cabrera Bueno F, Molina M, Fernandez-Pastor J, Pena J, Linde A, Barrera A, Alzueta J, Bremont C, Bensaid A, Alonso H, Zaghden O, Nahum J, Dubois-Rande J, Gueret P, Lim P, Lee SP, Park K, Kim HR, Lee JH, Ahn HS, Kim JH, Kim HK, Kim YJ, Sohn DW, Niemann M, Herrmann S, Hu K, Liu D, Beer M, Ertl G, Wanner C, Takenaka T, Tei C, Weidemann F, Silva D, Madeira H, Mendes Pedro M, Nunes Diogo A, Brito D, Schiano Lomoriello V, Ippolito R, Santoro A, Esposito R, Raia R, De Palma D, Galderisi M, Gati S, Oxborough D, Reed M, Zaidi A, Ghani S, Sheikh N, Papadakis M, Sharma S, Chow V, Ng A, Pasqualon T, Zhao W, Hanzek D, Chung T, Yeoh T, Kritharides L, Florescu M, Magda L, Enescu O, Mihalcea D, Suran B, Jinga D, Mincu R, Cinteza M, Vinereanu D, Ferrazzi E, Segato G, Folino F, Famoso G, Senzolo M, Bellu R, Corbetti F, Iliceto S, Tona F, Azevedo O, Quelhas I, Guardado J, Fernandes M, Pereira V, Medeiros R, Lourenco A, Sousa P, Santos W, Pereira S, Marques N, Mimoso J, Marques V, Jesus I, Rustad L, Nytroen K, Gullestad L, Amundsen B, Aakhus S, Linhartova K, Sterbakova G, Necas J, Kovalova S, Cerbak R, Nelassov N, Korotkijan N, Shishkina A, Gagieva B, Nagaplev M, Eroshenko O, Morgunov M, Parmon S, Velthuis S, Van Gent M, Post M, Westermann C, Mager J, Snijder R, Koyalakonda SP, Anderson M, Burgess M, Bergenzaun L, Chew M, Ohlin H, Gjerdalen GF, Hisdal J, Solberg E, Andersen T, Radunovic Z, Steine K, Rutz T, Kuehn A, Petzuch K, Pekala M, Elmenhorst J, Fratz S, Mueller J, Hager A, Hess J, Vogt M, Van Der Linde D, Van De Laar I, Wessels M, Bekkers J, Moelker A, Tanghe H, Van Kooten F, Oldenburg R, Bertoli-Avella A, Roos-Hesselink J, Cresti A, Fontani L, Calabria P, Capati E, Severi S, Lynch M, Saraf S, Sandler B, Yoon S, Kim S, Ko C, Ryu S, Byun Y, Seo H, Ciampi Q, Rigo F, Pratali L, Gherardi S, Villari B, Picano E, Sicari R, Celutkiene J, Zakarkaite D, Skorniakov V, Zvironaite V, Grabauskiene V, Sinicyna J, Gruodyte G, Janonyte K, Laucevicius A, O'driscoll J, Schmid K, Marciniak A, Saha A, Gupta S, Smith R, Sharma R, Bouzas Mosquera A, Alvarez Garcia N, Peteiro J, Broullon F, Prada O, Rodriguez Vilela A, Barge Caballero G, Lopez Perez M, Lopez Sainz A, Castro Beiras A, Kochanowski J, Scislo P, Piatkowski R, Grabowski M, Marchel M, Roik M, Kosior D, Opolski G, Van De Heyning CM, Magne J, O'connor K, Mahjoub H, Pibarot P, Pirlet C, Pierard L, Lancellotti P, Clausen H, Basaggianis C, Newton J, Del Pasqua A, Carotti A, Di Carlo D, Cetrano E, Toscano A, Iacobelli R, Esposito C, Chinali M, Pongiglione G, Rinelli G, Larsson M, Larsson M, Bjallmark A, Winter R, Caidahl K, Brodin L, Velthuis S, Van Gent M, Mager J, Westermann C, Snijder R, Post M, Gao H, Coisne D, Lugiez M, Guivier C, Rieu R, D'hooge J, Lugiez M, Hang G, D'hooge J, Guerin C, Christiaens L, Menard M, Voigt JU, Coisne D, Dungu J, Campos G, Jaffarulla R, Gomes-Pereira S, Sutaria N, Baker C, Nihoyannopoulos P, Bellamy M, Adhya S, Harries D, Walker N, Pearson P, Reiken J, Batteson J, Kamdar R, Murgatroyd F, Monaghan M, D'andrea A, Riegler L, Scarafile R, Pezzullo E, Salerno G, Bossone E, Limongelli G, Russo M, Pacileo G, Calabro' R, Kang Y, Cui J, Chen H, Pan C, Shu X, Kiotsekoglou A, Saha S, Toole R, Govind S, Gopal A, Crispi F, Bijnens B, Sepulveda-Swatson E, Rojas-Benavente J, Dominguez J, Illa M, Eixarch E, Sitges M, Gratacos E, Prinz C, Faludi R, Walker A, Amzulescu M, Gao H, Uejima T, Fraser A, Voigt J, Esmaeilzadeh M, Maleki M, Amin A, Vakilian F, Noohi F, Ojaghi Haghighi Z, Nakhostin Davari P, Bakhshandeh Abkenar H, Rimbas R, Dulgheru R, Margulescu A, Florescu M, Vinereanu D, Toscano A, Chinali M, D' Asaro M, Iacobelli R, Del Pasqua A, Esposito C, Mizzon C, Parisi F, Pongiglione G, Rinelli G, Jung BC, Lee BY, Kang HJ, Kim S, Kim M, Kim Y, Cho D, Park S, Hong S, Lim D, Shim W, Bellsham-Revell H, Tibby S, Bell AJ, Miller OI, Greil G, Simpson JM, Providencia RA, Trigo J, Botelho A, Gomes P, Seca L, Barra S, Faustino A, Costa G, Quintal N, Leitao-Marques A, Nestaas E, Stoylen A, Fugelseth D, Mornos C, Ionac A, Petrescu L, Cozma D, Dragulescu D, Mornos A, Pescariu S, Fontana A, Abbate M, Cazzaniga M, Giannattasio C, Trocino G, Laser K, Faber L, Fischer M, Koerperich H, Kececioglu D, Elnoamany MF, Dawood A, Elhabashy M, Khalil Y, Fontana A, Abbate M, Cazzaniga M, Giannattasio C, Trocino G, Piriou N, Warin-Fresse K, Caza M, Fau G, Crochet D, Xhabija N, Allajbeu I, Petrela E, Heba M, Barreiro Perez M, Martin Fernandez M, Renilla Gonzalez A, Florez Munoz J, Fernandez Cimadevilla O, Alvarez Pichel I, Velasco Alonso E, Leon Duran D, Benito Martin E, Secades Gonzalez S, Gargani L, Pang P, Davis E, Schumacher A, Sicari R, Picano E, Silva Ferreira A, Bettencourt N, Matos P, Oliveira L, Almeida A, Maceira Gonzalez AM, Cosin-Sales J, Igual B, Lopez Lereu M, Monmeneu J, Estornell J, Tsverava M, Tsverava D, Varela A, Salagianni M, Galani I, Andreakos E, Davos C, Ikonomidis I, Lekakis J, Tritakis V, Kadoglou N, Papadakis J, Trivilou P, Tzortzis S, Koukoulis C, Paraskevaidis I, Anastasiou-Nana M, Kim G, Youn H, Park C, Ibrahimi P, Bajraktari G, Jashari F, Ahmeti A, Poniku A, Haliti E, Henein M, Pezo Nikolic B, Jurin H, Lovric D, Baricevic Z, Ivanac Vranesic I, Lovric Bencic M, Ernst A, Separovic Hanzevacki J. Poster Session 3: Friday 9 December 2011, 08:30-12:30 * Location: Poster Area. European Journal of Echocardiography 2011. [DOI: 10.1093/ejechocard/jer214] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
39
|
Miyata M, Kusumoto A, Tei C. The Role of Natriuretic Peptides and Highly Sensitive Troponin T in Heart Failure. J Card Fail 2011. [DOI: 10.1016/j.cardfail.2011.06.404] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
40
|
Takasaki K, Miyata M, Tei C. Left Ventricular Dysfunction Assessed by Cardiac Time Analysis Among Different Geometric Patterns in Untreated Hypertension. J Card Fail 2011. [DOI: 10.1016/j.cardfail.2011.06.450] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
41
|
Kuwahata S, Miyata M, Fujita S, Kubozono T, Shinsato T, Ikeda Y, Hamasaki S, Tei C. Improvement of Autonomic Nervous Activity by Waon Therapy in Patients with Chronic Heart Failure. J Card Fail 2011. [DOI: 10.1016/j.cardfail.2011.06.424] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
42
|
Higuchi K, Takenaka T, Yoshimitsu M, Tei C. Heart Failure due to Fabry Disease. J Card Fail 2011. [DOI: 10.1016/j.cardfail.2011.06.437] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
43
|
Oketani N, Ichiki H, Iriki Y, Okui H, Ishida S, Maenosono R, Miyata M, Hamasaki S, Nademanee K, Tei C. Treatment of Heart Failure by Eliminating Atrial Fibrillation used Catheter Ablation Guided Solely by Complex Fractionated Atrial Electrogram Mapping. J Card Fail 2011. [DOI: 10.1016/j.cardfail.2011.06.391] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
44
|
Ichiki H, Orihara K, Hamasaki S, Ishida S, Oketani N, Iriki Y, Okui H, Kuwahata S, Fujita S, Tei C. The Up-Regulation of Toll-like Receptor 2 in Patients with Atrial Fibrillation and Atherosclerosis. J Card Fail 2011. [DOI: 10.1016/j.cardfail.2011.06.395] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
45
|
Kuwahara E, Hamasaki S, Tei C. [Echocardiography]. Nihon Rinsho 2011; 69 Suppl 7:180-184. [PMID: 22518988] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Affiliation(s)
- Eiji Kuwahara
- Department of Cardiovascular, Respiratory and Metabolic Medicine, Graduate School of Medicine and Dental Sciences, Kagoshima University
| | | | | |
Collapse
|
46
|
Kubozono T, Miyata M, Haseba J, Tei C. Effect and Safety of Combination of Waon Therapy and Exercise Training in Patients with Chronic Heart Failure. J Card Fail 2011. [DOI: 10.1016/j.cardfail.2011.06.632] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
47
|
Hirayama A, Tei C. The Journal of Cardiology receives its first impact factor. J Cardiol 2011; 58:83. [PMID: 21840175 DOI: 10.1016/j.jjcc.2011.07.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
48
|
Lee S, Hamasaki S, Yamashita M, Tei C. Reply. JACC Cardiovasc Imaging 2011. [DOI: 10.1016/j.jcmg.2011.06.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
49
|
Niemann M, Breunig F, Beer M, Hu K, Liu D, Emmert A, Herrmann S, Ertl G, Wanner C, Takenaka T, Tei C, Weidemann F. Tei index in fabry disease. J Am Soc Echocardiogr 2011; 24:1026-32. [PMID: 21719255 DOI: 10.1016/j.echo.2011.05.021] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/07/2010] [Indexed: 10/18/2022]
Abstract
BACKGROUND Systolic and diastolic dysfunction of the left ventricle are present in patients with cardiac involvement in Fabry disease. The aim of this study was to investigate the diagnostic value of the Tei index, a marker for combined diastolic and systolic function, in patients with Fabry disease. METHODS A total of 66 consecutive patients with genetically confirmed Fabry disease were included in this study. Standard echocardiography, including the Tei index, and magnetic resonance imaging were performed. Patients were followed for 2.9 ± 1.9 years; 56 patients received enzyme replacement therapy, and 10 patients had natural history follow-up. Patients were subdivided into three groups: (1) those without cardiac involvement, (2) those with left ventricular (LV) hypertrophy and without late enhancement on magnetic resonance imaging, and (3) those with late enhancement on magnetic resonance imaging. RESULTS The Tei index was significantly higher in the groups 2 (0.56 ± 0.10) and 3 (0.60 ± 0.16) compared with patients without cardiac involvement (0.44 ± 0.10) (P < .001). All patients with Tei indexes > 0.64 showed signs of cardiomyopathy. In contrast, ejection fractions were normal in all three patient groups and therefore not useful for the detection of cardiac involvement. A significant positive correlation was observed between LV wall thickness and the Tei index in the complete patient cohort. Moreover, receiver operating characteristic analysis revealed a large area under the curve for Tei index and hypertrophy, while the area under the curve for fibrosis was small. The Tei index remained unchanged in the natural history and enzyme replacement therapy groups during follow-up. CONCLUSIONS In this cohort, the Tei index was of limited value to detect myocardial fibrosis and monitor enzyme replacement therapy. However, the progression of cardiomyopathy toward LV hypertrophy seems to be paralleled by global functional impairment, which can be assessed by the Tei index but not by ejection fraction. Thus, the Tei index seems to be a global parameter that can detect LV functional reduction in patients with Fabry disease.
Collapse
Affiliation(s)
- Markus Niemann
- Department of Internal Medicine, University of Würzburg, Würzburg, Germany
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
50
|
Kimura T, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Iwabuchi M, Shizuta S, Shiomi H, Tada T, Tazaki J, Kato Y, Hayano M, Abe M, Tamura T, Shirotani M, Miki S, Matsuda M, Takahashi M, Ishii K, Tanaka M, Aoyama T, Doi O, Hattori R, Tatami R, Suwa S, Takizawa A, Takatsu Y, Takahashi M, Kato H, Takeda T, Lee JD, Nohara R, Ogawa H, Tei C, Horie M, Kambara H, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T. Long-term safety and efficacy of sirolimus-eluting stents versus bare-metal stents in real world clinical practice in Japan. Cardiovasc Interv Ther 2011; 26:234-45. [DOI: 10.1007/s12928-011-0065-0] [Citation(s) in RCA: 97] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2011] [Accepted: 04/05/2011] [Indexed: 11/29/2022]
|